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ABSTRACT 
 
ASSEMBLY AND FUNCTIONAL ARCHITECTURE OF BACTERIAL 
CHEMORECEPTOR NANOARRAYS 
 
FEBRUARY 2018 
 
ELIZABETH R. HAGLIN, B.S., SIMMONS COLLEGE 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Lynmarie K. Thompson  
 
 
Transmembrane chemotaxis receptors are found in bacteria in extended hexagonal 
arrays stabilized by the membrane and by cytosolic binding partners, the kinase CheA 
and coupling protein CheW. Models of array architecture and assembly propose receptors 
cluster into trimers-of-dimers that associate with one CheA dimer and two CheW 
monomers to form the minimal "core unit" necessary for signal transduction. 
Reconstructing in vitro chemoreceptor ternary complexes that are homogenous, 
functional, and exhibit native architecture remains a challenge. Here we report that His-
tag mediated receptor dimerization with divalent metals is sufficient to drive assembly of 
native-like functional arrays of a receptor cytoplasmic fragment. Our results indicate 
receptor dimerization initiates assembly and precedes formation of ternary complexes 
with partial kinase activity. Restoration of maximal kinase activity coincides with a shift 
to larger complexes, suggesting that kinase activity depends on interactions beyond the 
core unit. We hypothesize that achieving maximal activity requires building core units 
into hexagons and/or coalescing hexagons into the extended lattice. This discovery may 
also address a previously observed density-dependent transition between signaling states. 
To further test this, we implemented a paramagnetic relaxation enhancement (PRE) based 
  viii 
solid-state NMR approach to obtain long-range (≥ 20 Å) distance constraints across the 
trimer of dimers interface. Overall, the work presented here shows that minimally 
perturbing His-tag mediated dimerization promotes assembly of chemoreceptor arrays 
with native architecture, and thus enabled us to gain insights into the mode of array 
assembly and the role of the core functional unit. 
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CHAPTER 1 
 
BACTERIAL CHEMOTAXIS AND OVERVIEW OF THIS STUDY 
1.1. Introduction 
As gatekeepers of the cell, membrane proteins are crucial players in cellular 
homeostasis. Many bacteria and archaea rely on transmembrane proteins that govern 
signal transduction pathways to sense and adapt to their environment. One such pathway, 
the chemotaxis system, enables motile bacteria to track chemical gradients of attractants 
or repellents by transmitting information about the extracellular chemical environment to 
the flagellar motor in order to alter swimming direction. The membrane proteins 
responsible for this process, called chemoreceptors or methyl-accepting chemotaxis 
proteins (MCPs), regulate a histidine kinase CheA. CheA phosphorylates a response 
regulator protein CheY, which in turn controls the rotation of the flagellar motor. 
Chemoreceptors are typically anchored in the membrane and form stable ternary 
complexes with CheA and a coupling protein CheW. Together, these ternary complexes 
cluster into exquisitely sensitive and highly ordered polar arrays. Organized as a 
hexagonal lattice comprised of trimers of receptor dimers at each vertex, the architecture 
is remarkably conserved among bacteria and archaea (Briegel et al., 2009, 2012, 2015). 
The chemosensory proteins of Escherichia coli and Salmonella typhimurium are the most 
widely and thoroughly studied, due the limited number of components that retain a high 
degree of sophistication, and have therefore served as a model system for both 
chemotaxis and transmembrane signal transduction research alike. Despite the breadth of 
structural and functional knowledge available today, there are still a number of open 
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questions including how arrays assemble and influence receptor activity and how signals 
are propagated through the receptor cytoplasmic domain (Parkinson et al., 2015).  
In this work, we present a novel in vitro assembly method that can be used to 
trigger formation of functional and native-like arrays of the aspartate chemoreceptor 
cytoplasmic fragment (CF). This method makes it possible to follow the time course of 
assembly in a manner that could not previously be done with cryo-electron tomography 
(ECT) and with other assembly methods. The results provide an alternative view of the 
minimal unit for kinase activity and of a previous proposal that ligand-induced receptor 
expansion controls kinase activity. We initiated an NMR-based approach that sets the 
stage to obtain long-range distance constraints for the receptor trimer of dimers to test 
this proposal and to further define the receptor structure within the native array. Overall, 
this study provides a platform to follow assembly and test a proposed signaling-related 
conformational change.  
This chapter first describes how chemoreceptors and their component proteins 
work together to achieve chemotaxis. This is followed by a discussion of the structural 
features of chemoreceptors and the remarkable arrays they form. We then outline 
methods of assembly needed to generate in vitro chemoreceptor complexes and how 
those have and continue to be used to test mechanisms of signal propagation. Lastly, the 
key objectives and findings of this study are discussed.  
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1.2. Background 
1.2.1. Chemotaxis signal propagation, adaptation, and amplification 
Motile bacteria such as E. coli have four to six flagella driven by reversible rotary 
motors that are powered by the flux of ions (Berg, 2003). The direction of flagellar 
rotation dictates cellular movement. Cells swim forward with counter clockwise (CCW) 
rotation, which forms a flagellar bundle to propel the cell forward. Conversely, clockwise 
(CW) rotation causes the bundle to fall apart, leading to tumbling in place. 
Chemoreceptors localized at the cellular poles detect gradients of attractants (amino acids 
and sugars) or repellents (metal ions and acids) that bind to the periplasmic ligand-
binding domain. Mutational (Ames and Parkinson, 1988), cysteine-crosslinking (Chervitz 
and Falke, 1995), EPR (Ottemann, 1999), and NMR (Murphy et al., 2001; Isaac et al., 
2002) studies indicate that ligand binding induces a 2 Å piston-like motion of one 
transmembrane helix relative to the others within the dimer. It remains unclear how this 
signal then travels down the length of the cytoplasmic domain to the membrane-distal 
signaling subdomain to inhibit the kinase CheA. Since the signaling mechanism is known 
in this region, the work presented here focuses on the cytoplasmic domain. Together with 
a coupling protein CheW, ternary complexes exhibit kinase-on and kinase-off output 
states. As illustrated in Figure 1.1, attractant binding shifts the receptors to the kinase-off 
state, which in turn slows the flux of CheA phosphoryl groups (yellow circles labeled “P” 
in Figure 1.1) to the response regulators CheY and CheB. Phospho-CheY carries the 
signal to flagellar motor proteins, which subsequently induce CW rotation, leading to the 
cell tumbling in place.  
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Figure 1.1. The chemoreceptor signaling pathway in E. coli. For simplicity, the full-
length receptors (MCPs) are shown as single homodimers (monomers colored gray and 
black). In their native architecture, receptors form trimers of dimers in complex with the 
kinase CheA (blue when active) and CheW (cyan) (see Figure 1.3). Components shown 
in red reduce CheY-P levels and promote counter clockwise (CCW) flagellar rotation and 
a swimming response; those in green enhance CheY-P and lead to clockwise (CW) 
rotation and cellular tumbling. The small circles on receptor dimers indicate unmodified 
(white) or methylated (green) adaptation sites. The fully methylated receptor can be 
mimicked through mutations of the four sites to Glu (Q) in intact receptors or 
cytoplasmic fragments (CF).  
    
The exquisite sensitivity and large dynamic range of signal detection (10–7–10–3 
M) (Adler, 1969) is partly mediated through a sensory adaptation that effectively resets 
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the ON–OFF equilibrium to a pre-stimulus level. This is accomplished by covalent 
modification of several glutamyl residues located in the methylation subdomain of the 
receptor (Figure 1.2, white and green circles) (Springer et al., 1979). Ligand binding 
shifts the receptor to the kinase-off state and also increases the rate of methylation by the 
methyltransferase CheR, causing an immediate (~sec) decrease in tumbling frequency. 
Adaptation then occurs in minutes, when methylation shifts the receptor back toward the 
kinase-on state and resets the ligand affinity (Springer et al., 1979). Likewise, a 
methylesterase CheB—activated by the kinase-on state via phosphorylation by CheA—
hydrolyzes the receptor glutamyl ester to glutamic acid, resulting in a shift toward the 
kinase-off state. Both CheR and CheB are recruited to the receptor by a penta-peptide 
(NWETF) sequence on the flexible C-terminal tail (Wu et al., 1996).  
In the cell, signal transmission is amplified across interconnected and extended 
arrays of chemoreceptors. Remarkably, attractant binding to one receptor can regulate 
roughly 35 kinases within the array (Sourjik and Berg, 2002), Moreover, the attractant 
response is highly cooperative with Hill coefficients (nH) of 10–27 observed (Li and 
Weis, 2000; Sourjik and Berg, 2004; Han and Parkinson, 2014), depending on the 
preparation, receptor type, and methylation state. This indicates a high level of cross talk 
between receptors and/or CheA and CheW, and suggests that receptors operate in concert 
as allosteric arrays. Large polar patches of ternary complexes have been widely reported 
in cells by fluorescence imaging (Maddock and Shapiro, 1993; Gestwicki et al., 2000; 
Sourjik and Berg, 2000; Kentner and Sourjik, 2006) and electron cryotomography (ECT) 
(Zhang et al., 2007; Briegel et al., 2012; Liu et al., 2012). Furthermore, chemoreceptor 
arrays exhibit similar architecture among a diverse set of species, indicating a universally 
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conserved mechanism of receptor clustering (Briegel et al., 2009, 2015). Given the 
cooperativity and arrangement, it’s likely that interactions within the arrays are critical 
for function.  
1.2.2. Structural features of chemotaxis receptors and their complexes 
A considerable amount of structural information has been collected on soluble 
fragments and full-length forms of the chemotaxis proteins. Both X-ray and NMR 
structures have been deposited in the Protein Data Bank (PDB) for chemotaxis proteins 
and protein fragments originating from a number of species. We therefore have a broad 
understanding of many structural features for each of the chemosensory proteins.  
Chemoreceptors are intertwined transmembrane homodimeric proteins that are 
rod-shaped and predominantly α-helical. In addition to high-resolution x-ray structures of 
chemoreceptor fragments, electron microscopy has shown that each intact receptor dimer 
is approximately 380 Å long (Wadhams and Armitage, 2004) and oriented perpendicular 
to the membrane (Weis et al., 2003). As shown in Figure 1.2A, there are three functional 
elements: (1) a periplasmic sensing domain for ligand binding that connects to four 
transmembrane helices, (2) a cytoplasmic, membrane-proximal HAMP domain (found in 
histidine kinases, adenylyl cyclases, methyl-accepting chemotaxis proteins, and 
phosphatases (Aravind and Ponting, 1999)), and (3) a cytoplasmic signaling domain 
comprised of methylation, flexible bundle, and protein interaction subdomains.  
The x-ray crystal structures of the E. coli Tsr receptor cytoplasmic domain (Kim 
et al., 1999) and Thermatoga maritima TM1143 (Park et al., 2006), combined with 
mutagenesis studies (Falke and Kim, 2000) have shown that the signaling domain is 
predominantly a continuous four-helix, anti-parallel, coiled-coil with a hairpin turn at the 
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membrane-distal tip. The Tsr crystal structure revealed a trimer of receptor dimers 
(Figure 1.2B) architecture, which was further confirmed in vivo through cross-linking 
(Studdert and Parkinson, 2004; Parkinson et al., 2005). Remarkably, the five E. coli 
chemoreceptors share identical trimer contacts, allowing the lower abundance receptors 
(Tap, Trg, and Aer) to form mixed trimers with the higher abundance aspartate (Tar) and 
serine (Tsr) receptors (Gestwicki and Kiessling, 2002; Studdert and Parkinson, 2004; 
Gosink et al., 2006).  
Chemoreceptors bind CheA at their membrane-distal tips. CheA is a large 
histidine kinase consisting of five domains (P1–P5, domain organization shown in Figure 
1.3) that are connected by flexible linkers (Bilwes et al., 1999; Boukhvalova et al., 2002; 
Griswold et al., 2002; Wang et al., 2012a, 2012b). The P1 domain contains the histidine 
phosphorylation site. The response regulators CheY and CheB dock at the P2 domain. 
Dimerization of CheA is mediated through the P3 domain. P4 contains the active site for 
ATP binding and phosphorylation of P1. Lastly, P5 binds the receptor and CheW. 
Interestingly, P5 and CheW are structurally highly homologous. CheW plays a critical 
role in coupling CheA to the receptor to facilitate assembly and signaling, yet its precise 
function remains unclear.  
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Figure 1.2. Structure of dimeric chemoreceptors. (A) A ribbon model showing the 
predominantly α-helical structure of an intact chemoreceptor dimer is was based on 
crystal structures of the Tsr cytoplasmic domain (PDB: 1QU7 (Kim et al., 1999)), several 
periplasmic domain crystal structures, and a solution NMR structure of Tsr HAMP (PDB: 
2ASW) (courtesy of L.K. Thompson). Domain organization and functional regions are 
indicated and include: (1) periplasmic sensing domain, (2) HAMP domain, and (3) 
cytoplasmic signaling domain, comprised of three subdomains. The methylation sites 
within the methylation subdomain are shown in magenta. (B) A structural model of the 
cytoplasmic side of the trimer of dimers. This model (provided by A. Briegel, B. Crane, 
and G. Jensen) was generated by docking crystal structures of Tsr (1QU7) and ternary 
complex fragments (PDB 3UR1) into EM density (Briegel et al., 2012).   
 
 
Electron cryotomography has shown that chemoreceptor arrays can occupy 
membrane surface areas ranging from 12,000 to 144,000 nm2 in different species (Briegel 
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et al., 2009). The array features are remarkably similar: hexagonally packed lattices retain 
a 12 nm center-to-center spacing in at least 14 species of bacteria (Briegel et al., 2009) 
and archaea (Briegel et al., 2015). As previously discussed, chemoreceptor dimers 
associate in the membrane into trimers of dimers that are further constrained through 
direct contacts with CheA (Wang et al., 2012a; Li et al., 2013; Piasta et al., 2013) and 
CheW (Vu et al., 2012; Li et al., 2013; Pedetta et al., 2014) at the membrane-distal tip, 
thus forming a ternary complex. As depicted in Figure 1.3, the trimers of dimers reside at 
the vertices within a hexagonal lattice, surrounding a ring of alternating CheA regulatory 
domains (P5) and the structurally homologous CheW (Bilwes et al., 1999; Griswold et 
al., 2002), which form a stabilizing “baseplate”.  
 
 
Figure 1.3. Receptor core units and hexagonal arrays. A core signaling unit is comprised 
of two trimers of receptor (MCP) dimers (gray), one CheA dimer (blue) and four CheW 
monomers (cyan). Each CheA monomer has five domains (P1–P5); the two monomers in 
the dimer are shown in two shades of blue. A cross section at the receptor tip that is in 
line with P3-P5-CheW is rotated 90° to show the top down view (center). Core units 
combine to form the proposed architecture of extended hexagonal array (right) with 12 
nm center-to-center spacing (black line). The existence of a CheW-only ring (and two 
extra CheW in core unit) is currently in debate and discussed in Chapters 3–4.  
 
Due to their highly ordered nature, chemoreceptor arrays are well suited for ECT, 
and advances in the technique—including subvolume averaging—have enabled 
  10 
incredible three-dimensional images of both near-native cells and well-ordered in vitro 
assemblies at macromolecular resolution (~4 nm) (Briegel and Jensen, 2017). Such 
images have been used to create structural models of the array by docking crystal 
structures into the EM density. In addition to biochemical and high-resolution structural 
data, these structural models have significantly improved our understanding of the 
hexagonal lattice and its components. For example, a crystal structure of alternating 
CheW and CheA-P5 rings bound to receptor fragments (PDB 3UR1) with some rotations 
of its components, was fit into EM density, uncovering both the organization of CheA/W 
rings with respect to the trimer of dimers, and how CheA-P3 domains link the 
neighboring rings together (Briegel et al., 2012). In parallel, Liu and coworkers published 
a ~3.2 nm resolution electron density map imaged from in vivo arrays with nearly 
identical hexagonal architecture (Liu et al., 2012), which also revealed the existence of 
CheW-only rings (Figure 1.3). CheW-only rings have been also been observed by ECT 
for in vitro arrays of cytoplasmic fragments assembled onto monolayers (Cassidy et al., 
2015) and are proposed to provide array stability. However, these findings are in contrast 
to other studies, which found excess CheW disrupts both kinase activity and trimer 
formation (Studdert and Parkinson, 2005; Cardozo et al., 2010). The existence of CheW-
only rings is particularly interesting given the discrepancies in the field regarding its role 
and stoichiometry in the core unit and the arrays.  
1.2.3. Assembly of receptor complexes 
Chemotaxis by bacteria has been recognized for more than 135 years (Engelmann, 
1881), and has been the focus of intense studies for several decades (Adler, 1966). 
Methodologies have expanded from in vivo to a variety of in vitro systems as a way to 
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probe the molecular mechanisms in simplified and controlled environments. A widely 
used in vitro preparation consists of native membrane vesicles containing intact 
chemoreceptors (Borkovich et al., 1992; Li and Weis, 2000; Falke and Hazelbauer, 2001; 
Lai et al., 2005; Erbse and Falke, 2009; Amin and Hazelbauer, 2010). The disadvantages 
of these preparations include protein impurities and lack of control over receptor packing 
(Lefman et al., 2004) and orientation (Erbse and Falke, 2009). Additionally, recent ECT 
studies have shown a high degree of heterogeneity upon in vitro reconstitution with CheA 
and CheW to form signaling complexes. Array sizes varied from single trimers (inverted 
and outward facing in vesicles) to individual and linked hexagons, and hexagonal patches 
exhibiting both 9 nm and 12 nm center-to-center spacing (Briegel et al., 2014a). While 
some native functions are at least partly preserved (ligand binding, kinase inhibition, 
receptor adaptation), the challenges posed by the heterogeneity of these samples led to 
the development of improved assembly methods that recapitulate biological functionality 
using purified components in an environment that mimics the native membrane.  
Intact chemoreceptor trimers of dimers reconstituted into soluble nanodiscs form 
complexes with CheA and CheW that exhibit ligand control of kinase and methylation 
activities (Boldog et al., 2006). These ~10 nm nanodiscs are essentially plugs of lipid 
bilayers surrounded by an amphipathic membrane scaffold protein (Denisov et al., 2004), 
into which inactive, detergent-solubilized intact receptors will insert with random 
orientation and regain their function. The nanodisc dimensions prevent incorporation of 
more than one trimer of dimers, and maximal kinase activity is observed when receptors 
incorporated at levels of ≥ 5 dimers/nanodisc are reconstituted with CheA and CheW. It 
is proposed that kinase activity occurs in core units consisting of two trimers of dimers 
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(each in a separate nanodisc) that bind one CheA dimer and two CheW monomers (Li 
and Hazelbauer, 2011). This 6:1:1 stoichiometry of the core unit is consistent with some 
studies, but not others. Moreover, nanodisc assemblies are heterogeneous, with receptors 
in both orientations, and they lack the native array. 
In an effort to prepare homogenous in vitro complexes that restore the native 
array architecture, Weis and coworkers developed templating vesicles to serve as a 
membrane mimetic for soluble chemoreceptor cytoplasmic fragments (CF) that do not 
assemble into functional ternary complexes without the vesicles (Shrout et al., 2003).  
This approach, which has also been extended to lipid monolayers (Cassidy et al., 2015), 
utilizes the high-affinity interaction between the CF N-terminal hexahistidine-tag and a 
Ni2+-chelating phospholipid (DOGS-NTA-Ni2+). Recent ECT shows these templating-
vesicle complexes exhibit native-like hexagonal array architecture (Briegel et al., 2014a). 
Alternatively, CF can also be assembled into functional arrays using the molecular 
crowding agent PEG (Fowler et al., 2010). The PEG-mediated arrays exhibit a double 
layer array of chemoreceptors flanked by two CheA/W baseplates—so-called “sandwich” 
arrays, that retain the canonical 12 nm hexagonal spacing. While not native for the 
membrane-bound aspartate receptor, some other chemotactic species exhibit cytoplasmic-
only sandwich arrays. These have been imaged in Vibrio cholerae (Briegel et al., 2016), 
Rhodobacter sphaeroides (Briegel et al., 2014b), and Methanobacterium formicicum 
(Briegel et al., 2015).  
1.2.4. Current views and hypotheses for signaling mechanisms   
The mechanism of signal transduction within the periplasmic and transmembrane 
domains is widely thought to involve a 2 Å piston motion (Ames and Parkinson, 1988; 
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Ottemann, 1999; Falke and Hazelbauer, 2001; Murphy et al., 2001; Isaac et al., 2002). 
Thus, efforts are now focused on understanding signaling mechanisms within the 
cytoplasmic domain. Although CF arrays cannot be used to probe the effects of ligand 
binding, since the periplasmic, transmembrane, and HAMP domains have been removed, 
they are quite useful for investigating mechanisms of signal propagation through the 
cytoplasmic domain. Therefore, in vitro CF assembly methods have proven to be a 
powerful approach to probe chemotaxis signaling mechanisms in these regions, including 
signaling state dependent dynamics (Koshy et al., 2014; Kashefi and Thompson, 2017) 
and receptor conformational changes (Vaknin and Berg, 2007; Sferdean et al., 2012).  
The ligand-induced expansion model put forth by Sferdean, Thompson and 
coworkers is rooted in an observed density dependence of signaling output (Besschetnova 
et al., 2008). Besschetnova assembled cytoplasmic fragments (CF) of the aspartate 
receptor into arrays at the lowest (4E) and highest (4Q) levels of covalent modification. 
Increasing the receptor density—controlled by altering available lipid surface area per 
CF—resulted in a cooperative increase in kinase activity and FRET efficiency, which 
indicated a decrease in interdimer receptor distances, for CF4E. Moreover, low CF4E 
surface concentrations in the presence of CheA and CheW exhibited both decreased 
kinase activity and increased methylation activity, consistent with the inverse activity 
properties of the native receptor. Sferdean showed that reconstituted intact receptors 
retain similar ligand affinities at both low and high receptor densities, indicating 
receptors do not dissociate at low densities (Sferdean et al., 2012). From these combined 
results, it was proposed, as illustrated in Figure 1.4, that receptors undergo a signaling-
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related conformational change in which the trimers of dimers are expanded in the kinase-
off state, and more compact in the kinase-on state (Sferdean et al., 2012).  
 
 
Figure 1.4. Proposed ligand-induced expansion model for chemotaxis signaling. This 
model is based on observed density-dependent kinase activity and methylation for 
vesicle-assembled CF4E, combined with evidence for density-independent ligand affinity 
for reconstituted intact receptors (Besschetnova et al., 2008; Sferdean et al., 2012).  
 
Alternatively the observed density-dependent signaling could be a result of 
scattered core units when assembled at low densities (with an excess of vesicle surface 
area) that gain full activity upon formation of larger array units (eg a hexagon) when 
assembled at high densities. Ultimately, it remains unclear whether the density 
experiments are an effect of crowding or can be attributed to an increase in array size. 
1.3. Objectives  
Current views of the assembly mechanism for arrays are based solely on the 
variety of complexes observed by ECT in images of reconstituted receptor complexes 
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(Figure 1.5). While these images are suggestive of the proposed progression from trimers 
of dimers to core complexes to hexagons, methods are needed to directly monitor the 
time course of assembly of ternary complexes into hexagonal arrays and to determine 
when the system achieves each function.  
 
 
Figure 1.5. Tomographic evidence of small units lead to proposed model of assembly. 
(A) Smaller structures include (1) two linked trimers of dimers and (2) single hexagons 
containing six trimers of dimers. Hexagons are linked together in (B, 3) and are presumed 
to combine to form a hexagonal array patch (C, 4). Adapted from (Briegel and Jensen, 
2017).  
 
To address this, Chapter 3 describes a novel mode of assembling in vitro 
chemoreceptor arrays that mimic native structure and function. We show that soluble 
cytoplasmic fragments (CF) of the aspartate chemoreceptor fused with N-terminal His-
tags dimerize upon addition of divalent metals, and form arrays with native architecture, 
stoichiometry, and kinase activity. The metal-mediated His-tag dimerization strategy 
provides a new approach to stabilize multi-protein assemblies for analysis of protein 
mechanisms within their native complexes.  
Chapter 4 describes the use of this method to monitor the kinetics of assembly and 
gain insight into the mechanism and the minimum functional unit. ECT is best suited to 
detect large and highly ordered complexes, and thus cannot be used to detect small and/or 
less ordered species and to quantify the distribution of species during assembly of the 
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array. Therefore, we turned to size exclusion chromatography (SEC) to probe size 
changes over time. Other in vitro assembly methods for CF complexes are incompatible 
with SEC; vesicles are significantly larger than the proteins and would therefore mask the 
size changes that occur during assembly of the complexes, and the high concentrations of 
PEG8000 required for assembly would foul the column. The metal-mediated assembly, 
however, was perfectly suited for SEC analysis to track the process of assembly and 
probe array formation in parallel with kinase activity. We find that complete binding of 
CheA and CheW formation does not immediately yield full kinase activity. This suggests 
an alternative to the ligand-induced expansion model: rather than modulating an 
expansion/contraction transition of the receptor, high density assembly conditions may 
lead to higher activity by causing core units to coalesce into larger complexes.  
 Lastly, Chapter 5 lays the groundwork to obtain NMR distance constraints for the 
receptor trimer of dimers (which is absent in crystal structures of complexes and distorted 
in crystal structures of CF alone) and to test whether the trimer expands in the kinase-off 
state. We initiated a paramagnetic relaxation enhancement (PRE) based solid-state NMR 
approach to obtain long-range (≥ 20 Å) distance constraints across the trimer of dimers 
interface. By incorporating a nitroxide spin label with 75% efficiency, we are able to 
observe PRE effects in the membrane-proximal region of CF that are consistent with 
predictions based on the structural model.  
In summary, the work presented here uses a novel His-tag mediated assembly tool 
to provide new insights into the mode of chemoreceptor array assembly and the role of 
the core functional unit, and lays the groundwork to further interrogate signaling 
mechanisms in the context of the native array. 
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CHAPTER 2 
 
 
MATERIALS AND METHODS 
2.1. Proteins 
2.1.1. Expression Plasmids and Cloning 
The E. coli expression strain BL21(DE3) was used to overproduce all proteins 
used in this study. TEV-cleavable His-tagged CheA, CheW, and CheY plasmids were 
constructed by Aruni P. K. K. Mudiyanselage as previously described (Kashefi and 
Thompson, 2017). Expression plasmids for the aspartate chemoreceptor Tar cytoplasmic 
fragment (CF), containing residues 257-553 with an N-terminal hexahistidine-tag, encode 
glutamine at all four primary methylation sites (pHTCF4Q) or glutamic acid (pHTCF4E) 
and were previously constructed (Wu et al., 1996). A CF4E mutant (pCF4E.S487C) was 
generated previously (Mudiyanselage et al., 2013) and used in this study for spin labeling 
and NMR (see section 2.8.2 and Chapter 5). For protein production, all CF plasmids were 
co-transformed into BL21(DE3) with pCF430 (encoding lacIq and tetR).  
To generate a TEV-protease (tobacco etch virus)-cleavable His-tagged version of 
pHTCF4Q, the recognition and cleavage sequence for TEV-protease (ENLYFQG) was 
inserted directly following the N-terminal His6-tag of pHTCF4Q using site-directed 
mutagenesis and polymerase chain reaction (PCR). Forward (5’-
GAAAACCTGTATTTTCAGGGCGGA TCCCCTATGCAACG-3’) and reverse (5’-
GCCCTGAAAATACAGGTTTTCGTGATGGTGATGGTGATG-3’) overlapping 
primers were designed to include the TEV-protease recognition sequence and were 
purchased from Eurofins Genomics. The PCR reaction was done in a thermocycler (Bio-
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Rad MJ Mini), and reagents, including Phusion DNA polymerase, dNTPs, and DpnI were 
purchased from New England Biolabs. The PCR product (pTEVCF4Q, ampR) was 
subjected to DpnI digestion and transformed into DH5αF’ for plasmid purification. 
Following sequence verification (Genewiz), pTEVCF4Q was co-transformed with 
pCF430 (encoding lacIq and tetR) into BL21(DE3) for protein expression.  
2.1.2. Tar cytoplasmic fragment (CF) 
BL21(DE3) E. coli cells expressing H6CF (pHTCF4Q, ampR) or H6TEV-CF 
(pTEVCF4Q, ampR) co-transformed with pCF430 (tetR) were grown in Luria-Bertani 
(LB) broth with ampicillin (100 µg/mL) and tetracycline (10 µg/mL) at 37°C until the 
optical density at 600 nm reached approximately 0.6. The temperature was decreased to 
15°C for induction with 1 mM IPTG for 16–18 h. Cells were pelleted, resuspended in 
lysis buffer [75 mM KxHxPO4 (pH 7.5), 500 mM NaCl, 5 mM imidazole, and 1 mM 
EDTA], and lysed with a microfluidizer at 16K psi. PMSF (1 mM) was added every hour 
following cell lysis to limit proteolysis. Cell debris was separated by centrifugation and 
the supernatant applied to a HisTrap FF Ni2+-NTA affinity column (GE Healthcare) 
equilibrated with 10 column volumes of 75 mM KxHxPO4 (pH 7.5), 500 mM NaCl, and 5 
mM imidazole. The column was washed with 5 column volumes of 75 mM KxHxPO4 (pH 
7.5), 500 mM NaCl, and 50 mM imidazole, before elution with 75 mM KxHxPO4 (pH 
7.5), 500 mM NaCl, and 500 mM imidazole. Eluted protein was verified by SDS-PAGE 
and fractions were pooled prior to treatment with 5 mM EDTA to chelate any Ni2+ 
stripped from the column, followed by dialysis against 75 mM KxHxPO4 (pH 7.5) 75 mM 
KCl with 7 kDa molecular weight cutoff SnakeSkin tubing (Thermo Scientific) to remove 
EDTA and imidazole and to exchange high NaCl concentrations for low KCl 
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concentrations. Typically half of the purified H6TEV-CF was subjected to His-tag 
removal by TEV-protease cleavage. 
For isotopic labeling, BL21(DE3) cells harboring pCF4E.S487C (ampR) and 
pCF430 (tetR) were grown in M9 minimal media using natural abundance glucose and 
(15NH4)2SO4 as the carbon and nitrogen sources. Starter cultures were prepared from 
single colonies grown on LB amp/tet plates that were inoculated into ~5 mL LB broth 
supplemented with ampicillin (100 µg/mL) and tetracycline (10 µg/mL), and grown until 
~0.6 OD600 at 37°C. This was used to inoculate 1 L minimal media, which was typically 
grown overnight at 30°C with 200 rpm shaking until OD600 ~ 0.7–0.9. Protein production 
was induced with 1 mM IPTG for 5 h at 25°C. Cells were harvested and purification as 
described above, with the exception that 2 mM TCEP was included in all buffers except 
the final dialysis buffer for protein storage.    
2.1.3. TEV-cleavable His-tagged CheA, CheW, and CheY 
Plasmids encoding TEV-cleavable His-tagged CheA (pTEVcheA, kanR), CheW 
(pTEVcheW, kanR), and CheY (pTEVcheY, kanR) were expressed in BL21(DE3) and 
grown at 37°C in LB broth supplemented with 50 µg/mL kanamycin. At an optical 
density at 600 nm of ~0.7–0.9, 1 mM IPTG was added to induce expression for 3 h 
before the cells were harvested and purified with HisTrap affinity chromatography as 
described for CF (section 2.1.2). A different buffer system for CheA, CheW, and CheY 
purification was used: lysis buffer  [75 mM Tris-HCl (pH 7.4), 100 mM KCl, and 1 mM 
EDTA], equilibration buffer [75 mM Tris-HCl (pH 7.4), and 100 mM KCl], wash buffer 
[75 mM Tris-HCl (pH 7.4), 100 mM KCl, and10 mM imidazole], and elution buffer [75 
mM Tris-HCl (pH 7.4), 100 mM KCl, and 250 mM imidazole]. Following elution, 
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fractions containing protein were verified by SDS-PAGE, pooled and treated with 5 mM 
EDTA, then dialyzed as for CF into 75 mM Tris-HCl (pH 7.4) and 100 mM KCl prior to 
His-tag removal.  
2.1.4. TEV-protease 
The plasmid pRK793 (ampR) encoding N-terminally His-tagged TEV-protease (a 
gift from D. Waugh, Addgene plasmid 8827) (Kapust et al., 2001) was expressed in 
BL21(DE3)-RIL (ampR). Cells were grown at 37°C in LB broth containing 150 µg/mL 
ampicillin and 50 µg/mL chloramphenicol. When an optical density of 0.6 was reached, 
protein production was induced at 30°C with 1 mM IPTG for 4 h. The protein 
purification protocol and buffer system for CheA, CheW, and CheY was also used here 
(see section 2.1.3).  
2.1.5. His-tag cleavage 
Following purification, CheA, CheW, CheY, and H6TEV-CF were incubated with 
TEV-protease at a 50:1 His-tagged protein:TEV-protease molar ratio, and the mixture 
was shaken at 4°C overnight and then 25°C for 3 h. Complete cleavage was confirmed by 
a gel shift observed by SDS-PAGE. Cleaved proteins were separated from TEV-Protease 
by passage through the equilibrated HisTrap column, collected, and concentrated with 10 
kDa centrifugal concentrators (Amicon). Protein concentrations were measured with a 
BCA assay (Thermo Scientific), and proteins were frozen in liquid nitrogen and stored at 
-80°C.   
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2.2. Lipid Vesicles 
A mixture of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) and the nickel-
chelating lipid DOGS-NTA-Ni2+ (1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-
carboxypentyl)-iminodiacetic acid]succinyl}) (Avanti Polar Lipids) were combined in 
chloroform at a 1.5:1 DOPC:DOGS-NTA-Ni2+ molar ratio. Lipids were dried into a thin 
film with a stream of N2 gas and left under vacuum for 1 h before being rehydrated with 
1× PKB [phosphate kinase buffer: 50 mM KxHxPO4 (pH 7.5), 50 mM KCl, and 5 mM 
MgCl2] and vortexed extensively (30 s vortex, 5 min rest, repeated three times) to form 
multilamellar vesicles, followed by five cycles of 3-minute freezing/thawing. 
Freeze/thaw cycles were accomplished as follows: the lipids were dipped in liquid 
nitrogen for 20 s to freeze, left on the bench for 3 min, and then held for 3 min in a 37°C 
water bath. Extrusion was then performed with an extrusion apparatus (Avanti Polar 
Lipids) using a 100 nm diameter pore size polycarbonate membrane. High-concentration 
stocks at 3 mM total lipid (1.8 mM DOPC and 1.2 mM DOGS-NTA-Ni2+) were prepared 
and a final [lipid]total of 725 µM was used for assembly. The lipid concentrations were 
optimized in parallel with CheA and CheW concentrations to maximize kinase activity 
under conditions under which the available vesicle surface area could accommodate all 
CF as hexagonal arrays (See Appendix).  
2.3. Complex Assembly 
Preparation of ternary complexes was performed as previously described for 
vesicles (Shrout et al., 2003) and PEG (Fowler et al., 2010) with some modifications. 
Briefly, vesicle samples were prepared by combining the following (in order): autoclaved 
water, 1 mM PMSF dissolved in 100% ethanol, phosphate kinase buffer (PKB) from 5x 
  22 
stock, 12 µM CheA, 24 µM CheW, 30 µM CF (H6CF, H6TEV-CF, or ΔH6CF), 725 µM 
vesicles. PEG-assembled samples were made by combining the following (in order): 
autoclaved water, 1 mM PMSF, PKB, 12 µM CheA, 20 µM CheW, 50 µM CF (H6CF, 
H6TEV-CF, or ΔH6CF), 7.5% w/v PEG8000 (from a 40% w/v stock), 4% w/v D-trehalose 
(from a 40% w/v stock). Metal-assembled samples were prepared under protein and 
buffer conditions equivalent to those optimized for vesicle-assembly, except that vesicles 
were replaced with metal salts (NiCl2•6H2O, ZnCl2 anhydrous, CuCl2•2H2O, 
MnCl2•4H2O, and CoCl2•6H2O, all obtained from Sigma-Aldrich) prepared at ~1 mM in 
autoclaved Milli-Q H2O. Metal stock concentrations were verified before use (see section 
2.5). All metal-mediated assembly experiments outside of the metal titration (see section 
3.2.1) used metal concentration conditions that produced the largest quantity (based on 
sedimentation) of maximally active complexes (NiCl2 was 180 µM, ZnCl2 was 300 µM, 
and CoCl2 was 360 µM). For the mixed NiCl2 and PEG-mediated CF4E assembly (see 
section 3.2.7), 180 µM NiCl2, 7.5% w/v PEG, and 4% w/v D-trehalose were used; protein 
concentrations matched those of PEG-mediated assembly). 
Once combined, samples were incubated in a 25°C water bath for 4 h or overnight 
before use. For kinetic experiments, biochemical assays or SEC-MALS were performed 
at time points immediately following addition of all complex components. 
2.4. Biochemical Assays 
2.4.1. CheA kinase activity 
Kinase activity was measured using an enzyme-coupled ATPase assay that 
couples NADH oxidation to consumption of ATP (Nørby, 1988; Shrout et al., 2003). 
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Briefly, activity measurements were conducted immediately following a 100-fold dilution 
of assembled complexes into PKB containing 55 µM CheY, 2.2 mM 
phosphoenolpyruvate, 4 mM ATP, 250 µM NADH, and 20 units of PK/LDH enzyme 
(Sigma-Aldrich). New CheY preparations were tested at both 55 µM (1X) and 110 µM  
(2X) to confirm the rates were unchanged and excess CheY was available so that 
phosphorylation of CheA was rate limiting. The background activity of CheY under 
identical conditions in the absence of the complex was subtracted before calculation of 
kinase activity. The kinase activity (inverse seconds) was determined from the linear 
change in absorbance at 340 nm [d[ATP]/dt = –6220(dA340/dt)] over 1.5 min. Total 
activity is based on the full amount of CheA in the sample (12 µM), which is divided by 
the amount of CheA in the complex (quantified by sedimentation, as described in 2.4.2) 
to compute the specific activity of CheA in complexes with CF.    
2.4.2. Binding assay 
The amount of bound protein was determined with a sedimentation assay carried 
out at 25°C in a benchtop ultracentrifuge (Beckman TLX, TLA 120.2 rotor, 125,000g, 30 
minutes). Typically, a 35 µL aliquot of sample (in either assembled ternary complexes or 
individual proteins) was centrifuged. Following sedimentation, the supernatant was 
carefully removed and placed into a clean Eppendorf tube to minimize contamination of 
free protein in the pellet containing the bound fraction of proteins. The pellets were 
slowly resuspended to the original volume in autoclaved Milli-Q H2O and vortexed to 
homogenize resuspension. Aliquots of Total (free plus bound protein, before 
sedimentation), Supernatant (free protein), and Pellet (bound protein) were run on SDS-
PAGE (12.5% acrylamide) and stained with Gel-code Blue (Pierce Chem. Co.). Gels 
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were imaged by densitometry with a Gel Doc EZ Imager (Bio-Rad) and the integrated 
intensities were analyzed with ImageJ software.(Schneider et al., 2012) The bound 
concentrations were computed as (IPellet/ITotal) x [Protein]Total for each protein to be 
quantified. For the excess CheA and CheW conditions used in this study, quantification 
of bound protein by the pellet was more reproducible than (ITotal – ISupernatant). [For future 
studies, we suggest making the Pellet gel sample from the entire resuspended pellet. This 
might further increase reproducibility, by making it unnecessary to achieve a complete 
and homogeneous resuspension of the pellet.] Gels included two additional lanes of the 
Total sample diluted 6x and 12x such that a calibration curve from three intensities for 
known concentrations could be calculated. The y-intercept was then subtracted from each 
integrated intensity to correct for the gel background intensity and more accurately 
estimate the fraction of protein bound in a complex.  
2.4.3. Methylation assay 
Methylation assays were carried out on various complexes following overnight 
assembly. Vesicle- and Ni(II)-mediated assemblies were prepared normally (section 2.3), 
while NiCl2 + PEG-mediated assemblies contained: 180 µM NiCl2, 7.5% PEG8000, 4% 
D-trehalose, 50 µM CF, 12 µM CheA, and 20 µM CheW. Methylation was initiated upon 
the addition of 6 µM CheR (prepared previously by Guoyong Li) and 10 µM S-adenosyl-
L-methionine (SAM, Sigma Aldrich). Aliquots were removed after 0.1 and 4 h, quenched 
by the addition of gel-loading buffer, and analyzed by SDS-PAGE. Quantification was 
done with ImageJ (Schneider et al., 2012). 
  25 
2.5. Inductively Coupled Plasma Optical Emission Spectroscopy 
Metal concentrations of the ~1 mM aqueous metal stocks (NiCl2, ZnCl2, CuCl2, 
MnCl2, CoCl2) and the amounts of metal bound to H6CF (alone or in complex) were 
measured using a PerkinElmer Optima DV4300 inductively coupled plasma optical-
emission spectroscopy (ICP-OES) instrument. Metal standards (TraceCERT by Sigma-
Aldrich) were used to produce a calibration curve for each metal at 0.1, 0.2, 0.75, 1, 2, 
and 10 ppm. Metal stocks were diluted 100-fold and protein-metal samples were diluted 
10-fold into MilliQ water that was also used to blank the instrument. Protein samples 
were prepared by overnight incubation of 30 µM H6CF (alone or with 12 µM CheA and 
24 µM CheW) with the metals at the optimal concentrations that produced active 
complexes (180 µM NiCl2, 300 µM ZnCl2, or 360 µM CoCl2) in a 25°C water bath. 
Aliquots of these samples were then subjected to ultracentrifugation (60k rpm for 30 
minutes at 25°C) to separate large metal-protein complexes from unbound protein and 
metal in the supernatant. Bound protein and metals in the pellet were carefully 
resuspended to the initial volume in MilliQ water. The entire resuspended pellet was used 
for ICP-OES analysis so that any chunks of protein pellet were still part of the sample 
measured.  
2.6. Size Exclusion Chromatography with Multi-Angle Light Scattering 
Size exclusion chromatography and multi-angle light scattering (SEC-MALS) 
was used to monitor metal-mediated complex formation. The SEC is coupled to an 18-
angle static light scattering detector (DAWN HELEOS-II), a dynamic light scattering 
detector (WyattQELS), and a differential refractometer (Optilab T-rEX, Wyatt 
Technology). Proteins were injected onto a TSKgel G2000SWXL column maintained at 
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4°C and pre-equilibrated overnight with PKB buffer (pH 7.0) kept on ice. Typical 
injections were 75 µL of 0.5-3 mg/mL protein. Data was collected every second for 30 
minutes at a flow rate of 0.5 mL/min. Protein elution was monitored at A280 and A214, in 
addition to static and dynamic light scattering. The accompanying ASTRA VI software 
was used to determine molar mass, peak polydispersity, and UV peak areas for all 
individual peaks and the entire elution to determine % loss in the pre-column 0.22 µm 
filter.  
2.7. Electron Cryo-Tomography (ECT) 
All ECT presented in this study was done by our collaborators Ariane Briegel and 
Wen Yang at the NeCEN Facility run by the University of Leiden. Samples were 
prepared by mixing protein assemblies (see section 2.3) with a bovine serum albumin-
treated 10 nm colloidal gold solution (Cell Microscopy Core, Utrecht University, Utrecht, 
The Netherlands). After brief vortexing, 3 µL mixtures were applied to freshly plasma-
cleaned R2/2 copper Quantifoil grids (Quantifoil Micro Tools). Blotting and plunge 
freezing in ethane were done in approximately 1 second with a Leica EMGP (Leica 
microsystems, Wetzlar, Germany), set at 20°C and 95% humidity. Grids were stored in 
liquid nitrogen until imaging. Data was collected on a Titan Krios transmission electron 
microscope from Thermo Fisher Scientific (formerly FEI; Hillsboro, Oregon) with a field 
emission gun operating at 300 kV. The microscope was equipped with a Gatan 
(Pleasanton, CA) image filter and a Gatan K2 Summit direct electron detector. Data 
acquisition was done using Tomography 4.0 (Thermo Fisher Scientific) in batch mode. 
Tilt series for PEG and Ni(II)-assembled H6CF ternary complexes were collected at a 
nominal magnification of 42,000x and 33,000x, respectively. A discontinuous tilt scheme 
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was used for imaging, taking images from 0° to −60° followed by 0° to +60° with a 2° 
tilting increment. The cumulative dosage for each tilt series was 80 e/A2. Defocus was set 
to -8 µm. The tilt series for Ni(II)-assembled H6CF (without CheA or CheW) and PEG-
assembled ΔΗ6CF complexes were collected using the same tilt scheme but at a defocus 
of -300 nm with volta phase plate (VPP) (Thermo Fisher Scientific). The VPP was heated 
to 225°C and activated for 80s before each tilt series aiming to generate an approximate 
phase shift of 90° (Danev et al., 2014). An extra 5s conditioning time was applied 
between each tilt image. All images were acquired using the low-dose routine integrated 
in the Tomography software. Drift correction and tilt series alignment were performed 
with software package IMOD (Kremer et al., 1996; Mastronarde, 1997). Tomograms 
were reconstructed using both weighted back-projection (WBP) and 9 iterations of 
simultaneous iterative reconstruction (SIRT). PEET was used for subvolume averaging 
(Nicastro et al., 2006). Visualization and image analysis were carried out with Image J 
and Chimera (Pettersen et al., 2004; Schneider et al., 2012). 
2.8. Solid-State Nuclear Magnetic Resonance 
2.8.1. Paramagnetic spin labeling 
The nitroxide paramagnetic spin label MTSL [(1-oxyl-2,2,5,5-tetramethyl-Δ3-
pyrroline-3-methyl)methanethiosulfonate] was purchased from Toronto Research 
Chemicals, immediately solubilized in 100% acetonitrile to a stock concentration of 100 
mM, and stored at –20°C wrapped in parafilm and aluminum foil to prevent evaporation 
and light damage.  
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To prepare the CF4E.S487C for labeling, dimers were first reduced with a 5 mM 
TCEP treatment for 30 min in a 25°C water bath. Approximately 2 mL protein was 
injected per 5 mL HisTrap desalt column (GE Healthcare) equilibrated with 75 mM 
KxHxPO4 (pH 7.4) and 50 mM KCl using a 5 mL syringe. For larger protein volumes, 
multiple 5 mL desalt columns were used in series. Initially, the flow through was 
collected in 0.5 mL fractions and the protein was eluted at 2.0–4.5mL (as monitored by 
A280 and SDS-PAGE). This elution profile was highly reproducible for a 2 mL injection 
volume into a single 5 mL column, and generally imparted a 1.3-fold dilution. It took at 
least 1.5 hours following the TCEP removal desalt column to identifying the protein-
containing fractions with SDS-PAGE so this step was eliminated once the reproducibility 
of the desalt elution profile was confirmed. A number of spin labeling protocols were 
tested, including binding the protein to a Ni2+-affinity column and flowing an 800 µM 
MTSL solution (25 mL of 75 mM KxHxPO4 (pH 7.4), 50 mM KCl and 200 µL of 100 
mM acetonitrile-dissolved MTSL) through the column in a loop overnight, and 
incubation of 200–800 µM CF with 20-fold excess MTSL in 75 mM KxHxPO4 (pH 7.4) 
and 50 mM KCl for times and temperatures ranging from 4–72 hours and 4–25°C. We 
found that the least dimers formed when the protein was eluted from the desalt column 
for TCEP removal directly into a tube containing a 20-fold molar excess of MTSL to 
minimize dimer formation. This solution was then left gently stirring overnight at 4°C. 
MTSL was subsequently removed with another desalt column, and the eluted protein 
concentration was measured by BCA assay, since MTSL absorbs light at 280 nm (a 1 
mM solution of MTSL in water is ~0.7 at 280 nm, but does not react with the BCA assay 
reagents).  
  29 
2.8.2. NMR Sample preparation 
Each NMR sample was assembled as 14 mL of the vesicle-mediated complex and 
incubated at 25°C overnight. The kinase activity and sedimentation were measured prior 
to packing the NMR rotor to confirm successful assembly. Total kinase activities were 
typically 5–7 s–1 and protein binding stoichiometries were ~ 6 CF:1 CheA:2 CheW. The 
samples were pelleted by ultracentrifugation for 2.5 h at 25°C with 24,000 rpm in a 
Beckman Ti70 rotor. The pellet was packed into a 50 µL restricted volume 4 mm Bruker 
rotor by first transferring the pellet to a 200 µL flame-sealed pipette tip with a spatula. 
The tip was placed into a test tube, stabilized with Kimwipes, and gently centrifuged (a 5 
second pulse up to ~6k rpm) to move the pellet to the tip base. The flame seal was 
removed with a razor and inserted into the rotor and centrifuged as before. The top plastic 
insert and cap were then used to estimate the level to pack the rotor, and subsequently 
used to seal it tightly. Approximately 45 mg of assembled complex were packed into 
each rotor. The mass of CF in each sample was calculated as (total volume of complex) ×	 
(CF concentration) ×	 (packed sample weight)/(total pellet weight), resulting in ~286 
nmol of labeled CF for both MTSL-labeled and non-labeled U-15N-CF4E.S487C NMR 
samples.   
2.8.3. Spectroscopy and data analysis 
All NMR experiments were done on a 14.1 T Bruker Avance III spectrometer (1H 
= 600 MHz, 13C = 150 MHz, 15N = 60 MHz) in a 4 mm E-free HCN probe. Sample 
temperature was estimated by a calibration of the chemical shift changes of TmDOTP 
(Zuo et al., 1998) dissolved in DMPC vesicles at ionic strengths similar to protein 
samples; heating due to decoupling and MAS was counterbalanced with VT gas flow 
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cooling, for an effective sample temperature of ~10–15°C. A one-dimensional (1D) 
sequence for cross-polarization/magic angle spinning (CP/MAS) was used with 11.1 kHz 
MAS, a contact time of 1.5 ms, and a recycle delay of 1 s. The 90° pulses were 2.8 µs and 
5.6 µs for 1H and 15N, respectively, with SPINAL-64 1H decoupling at 92.5 kHz. Each 
1D spectrum contained the combined FIDs for 9600 scans (collected in 2400 scan 
blocks), for a total experiment time of ~3 hr.  
Topspin 3.2 was used for all data processing. Chemical shifts were referenced to 
adamantane at 40.5 ppm (relative to DSS at 0 ppm), and no line broadening was applied. 
Spectra for with or without spin label were overlaid in the Topspin multiple display 
feature without additional scaling; the difference spectrum was likewise created using the 
Topspin, but the intensity was scaled up 2-fold for the final comparison in Figure 5.6. 
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CHAPTER 3 
 
 
METAL-MEDIATED HIS-TAG DIMERIZATION FOR ASSEMBLY OF 
CHEMORECEPTOR ARRAYS 
 
This chapter describes the use of divalent metals to initiate chemoreceptor His-tag 
dimerization and drive assembly of native-like arrays in vitro. Most of this chapter was 
published in the article “His-tag-mediated dimerization of chemoreceptors leads to 
assembly of functional nanoarrays” in Biochemistry (Haglin et al., 2017).  
3.1. Introduction 
Many fundamental biological processes are carried out by multi-protein 
complexes (Alberts, 1998; Marsh and Teichmann, 2015). To fully understand how these 
processes occur within the cell, methods are needed both for monitoring such processes 
in vivo and for isolation and/or reassembly of such complexes for in vitro structure–
function analysis. Isolation and reassembly of complexes often requires modifications or 
deletions of portions of the protein components: for instance, deletion of transmembrane 
domains of membrane proteins may be needed to prepare homogeneous complexes for 
structural or biophysical studies. Typically, such truncations also delete stabilizing 
interactions, and it becomes difficult to reassemble complexes with native-like 
architecture and activity. We have developed a novel strategy for the stabilization of 
assemblies with native structure and activity for in vitro mechanistic studies. 
Bacterial chemotaxis receptors are an ideal system for understanding the 
molecular details of signal transduction by membrane proteins and their complexes. 
Chemotaxis receptors are dimeric transmembrane proteins anchored in the inner–
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membrane in large patches at the poles of the cell, which are responsible for sensing and 
responding to environmental stimuli. Upon ligand binding to the receptor periplasmic 
domain, a signal is transmitted down the ~300 Å length of the receptor to control the 
autophosphorylation activity of an associated histidine kinase, CheA, which plays a 
central role in the signal transduction pathway. In addition to forming a complex with 
CheA and an adapter protein CheW, receptors form large clusters (a membrane surface 
area of 53000 nm2 for E. coli) (Maddock and Shapiro, 1993; Zhang et al., 2007; Briegel 
et al., 2009) that enable extraordinary levels of cooperativity and sensitivity (Sourjik and 
Berg, 2002, 2004). The native system is built of trimers of receptor dimers that each form 
one vertex of a hexagon within the membrane and are stabilized at the membrane-distal 
tip of the receptor by hexagonal rings of alternating CheA and CheW (Briegel et al., 
2012; Liu et al., 2012; Cassidy et al., 2015). It is challenging to prepare homogeneous 
samples of functional chemoreceptor complexes in vitro for structure–function analysis. 
Complexes of the intact membrane-bound receptor with CheA and CheW are not 
homogeneous, in part due to the inability to control orientation of the receptor within 
membrane vesicles (Sferdean et al., 2012; Briegel et al., 2014a) or nanodiscs (Boldog et 
al., 2006). In principle, the membrane orientation issue can be addressed by using a 
cytoplasmic fragment of the receptor, but this truncated construct does not form 
functional complexes with CheA and/or CheW in solution. Presumably, this is because 
the missing transmembrane and periplasmic domains are needed to provide protein–
protein interactions that stabilize the receptor dimer and geometrical alignment within the 
membrane that promotes assembly of the array. 
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In an elegant combination of membrane mimetics and nano-scale assembly tools, 
Weis and coworkers developed templating vesicles that promote the assembly of 
membrane-associated multi-protein complexes from soluble component proteins. This 
technology harnesses the high affinity interaction between histidine imidazole groups and 
the Ni(II)-NTA functional group originally developed for immobilized metal affinity 
chromatography protein purification (Hochuli et al., 1987). The N-terminally His-tagged 
cytoplasmic fragment (CF) of the aspartate chemoreceptor binds to vesicles containing 
lipids with nickel-chelating headgroups (DOGS-NTA), which enables binding of CheA 
and CheW into ternary complexes with kinase and methylation activity that mimic native 
signaling states (Shrout et al., 2003; Besschetnova et al., 2008). Molecular crowding 
agents such as PEG8000 provide an alternate means of driving assembly of functional 
complexes, with no requirement for membrane vesicles (Fowler et al., 2010). Both 
assembly methods result in extended hexagonal arrays with native-like architecture 
(Briegel et al., 2014a), and PEG-mediated assembly forms sandwich lattices remarkably 
similar to cytoplasmic chemoreceptor arrays seen in some bacterial species (Briegel et al., 
2014a, 2016) 
Here we report a novel method for assembling functional arrays in vitro. We show 
that adding divalent metal salts to ternary mixtures of His-tagged CF, CheA, and CheW 
promotes receptor dimerization and assembly into active complexes with native 
stoichiometry and architecture. This dimerization strategy may prove to be valuable for 
assembly of other complex systems, particularly given the widespread use of 
polyhistidine-tags as a convenient and effective affinity tag capable of facilitating a 
variety of applications.  
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Cornelissen, van Hest, and coworkers discovered that metal-ion-induced 
interactions between His tags could be used to stabilize a capsid assembly that is 
otherwise unstable in the absence of a high negative charge from either encapsulated 
RNA or low pH. By the simple addition of divalent metals to the His-tagged cowpea 
chloric mottle virus capsid protein, capsid structures with native particle size form at 
neutral pH and can be used to encapsulate other proteins or drugs (Minten et al., 2011; 
Van Eldijk et al., 2016). Their model suggests the metal promotes His-tag-to-His-tag 
interactions that stabilize the large oligomeric capsid structure. This chapter describes a 
similar phenomenon that we demonstrate is a metal-mediated dimerization. His-tag 
mediated dimerization provides a new approach to stabilize multi-protein assemblies for 
analysis of protein mechanisms within their native complexes. 
3.2. Results and Discussion 
3.2.1. Divalent metals restore chemoreceptor ternary complex formation and 
function 
Assembling aspartate chemoreceptor cytoplasmic fragments (CF) into functional 
arrays with CheA and CheW has thus far been accomplished with templating vesicles 
(Shrout et al., 2003), lipid monolayers (Cassidy et al., 2015), and with molecular 
crowding agents (Fowler et al., 2010). Under conditions similar to those used to form 
functional complexes with templating vesicles, we have discovered that some divalent 
metals are sufficient to restore function, with no requirement for vesicles. A series of 
metal titrations reveal the conditions needed to restore both kinase activity of CheA 
(measured with an enzyme-coupled ATPase assay, using the native phosphoryl acceptor 
protein CheY) and ternary complex formation (measured with sedimentation assays). 
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Five divalent metal chlorides were tested (NiCl2, ZnCl2, CoCl2, CuCl2, and MnCl2) at 
concentrations ranging from 0 to 540 µM, while keeping protein concentrations constant 
at levels that promote maximal incorporation of CF into functional complexes (30 µM CF 
plus excess CheA (12 µM) and CheW (24 µM)). As shown in Figure 3.1, NiCl2 promotes 
active complex formation at the lowest concentrations, with maximum kinase activity 
reached at 180 µM NiCl2. The optimal ZnCl2 concentration for kinase activity is 300 µM, 
and the total kinase activity is 90% of the highest observed for NiCl2. While CoCl2 also 
produced active complexes in this titration series, the highest kinase activity (reached at 
360 µM CoCl2) is only 50% of the optimal NiCl2 sample. Thus the relative efficiency of 
these metals for promoting assembly of functional complexes is NiCl2 > ZnCl2 > CoCl2. 
Interestingly, the sedimentation trends for CF, CheA, and CheW with each metal titration 
track mostly with the respective onset of activity (Figure 3.2). For example, NiCl2-
assembled complexes show both activity and sedimentation beginning at low NiCl2 
concentrations, and ZnCl2-assembled complexes show nearly zero sedimentation until 
180 µM ZnCl2, where activity is first observed. Furthermore, maximal sedimentation of 
CF, CheA, and CheW is reached for most cases under conditions that give maximal 
activity, and the CoCl2 titration reaches activity and sedimentation of only 50% of the 
optimal NiCl2 sample. Thus three divalent metals restore the ability of the chemotaxis 
receptor CF to assemble with CheA and CheW into sedimentable complexes that activate 
the kinase CheA.  
Interestingly, NiCl2 concentrations higher than 180 µM are clearly detrimental to 
kinase activity, and sedimentation of CF increases an additional 15%, while CheA and 
CheW sedimentation remain constant (Figure 3.2). In contrast, ZnCl2 and CoCl2 cause 
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only a modest decrease in activity at high concentrations (and no significant additional 
sedimentation). 
Neither CuCl2 nor MnCl2 restored formation of active complexes. Kinase activity 
throughout the titration is similar to that of the proteins with no metal (< 1s-1). 
Furthermore, all samples with CuCl2 and MnCl2 also had very low protein sedimentation 
of <15%, again similar to levels for the no-metal control, with the exception of CuCl2 and 
CheA. At high [CuCl2], nearly all of CheA sedimented (data not shown). Since there is 
no appreciable kinase activity or sedimentation of CheW and H6CF, we can conclude that 
CuCl2 is most likely causing aggregation of CheA.  
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Figure 3.1. Three divalent metals promote kinase. All experiments use excess CheA and 
CheW, under conditions optimized for maximal incorporation of CF into complexes with 
maximal kinase activity (30 µM H6CF, 12 µM CheA, 24 µM CheW). Additions of NiCl2 
(filled circles), ZnCl2 (filled triangles), or CoCl2 (filled diamonds) each promote kinase 
activity, with NiCl2 promoting the highest activity, followed by ZnCl2 and then CoCl2. 
Both CuCl2 (open circles) and MnCl2 (open triangles) do not promote activity: activity 
comparable to the no-metal control is observed at all metal concentrations. As a positive 
control, PEG-mediated samples were run in parallel, with typical total kinase activities 
~11 s-1. Arrows denote maximally active conditions used for further studies, including 
metal:protein stoichiometry measurements listed in Table 3.1. Activities are averages of 
four to eight replicates measured on two or three days; error bars indicate ± one standard 
deviation. For this plot, measurements on each day were averaged, and the averages for 
all days were then combined, with propagation of the errors. Reprinted (adapted) with 
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society. 
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Figure 3.2. Divalent metals that promote kinase activity also lead to protein 
sedimentation. Quantification of H6CF, CheA, and CheW sedimentation for (A) NiCl2, 
(B) ZnCl2, and (C) CoCl2 titration samples shown in Figure 3.1. All samples contain 30 
µM H6CF, 12 µM CheA, and 24 µM CheW, but sedimentation is typically less than 
100%, particularly for CheA and CheW which are added in excess to drive assembly. 
Approximate stoichiometries of the functional complexes were estimated used averages 
of the sedimented concentrations for all sample conditions with maximal activity (gray 
shaded region): 6:1.3:2.9 for Ni(II)-mediated assembly, 6:1.2:2.7 for Zn(II)-mediated 
assembly, and 6:0.9:2.7 for Co(II)-mediated assembly. Reprinted (adapted) with 
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society. 
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3.2.2. Stoichiometry of metal bound to receptor  
Measurements of bound metals indicate that the active complexes have 
metal:protein stoichiometries close to 1:1 (Ni(II) and Co(II)) and 3:1 (Zn(II)). The metal 
ion concentrations bound to CF were determined using inductively coupled plasma 
optimal-emission spectroscopy (ICP-OES), in samples of active complexes (prepared 
with CheA and CheW) as well as CF alone. Metals producing active complexes lead to 
sedimentation of both CF alone and CF with CheA and CheW (with the exception of 
CoCl2 + CF alone, which does not sediment). Samples were prepared with each metal at 
the optimal concentration based on the activity data (Figure 3.1, arrows) and incubated 
for long assembly times that maximize kinase activity (greater than 4 h). The bound 
protein (CF alone or in complex with CheA and CheW) and metal were separated from 
free protein and metal by ultracentrifugation. Resuspended pellets were then analyzed for 
metal content by ICP-OES, and protein content by SDS-PAGE (via comparison to a CF 
standard measured with a BCA assay). Unfortunately we were unable to implement 
sulfur quantification by ICP-OES, which would have enabled measurement of a more 
accurate metal:protein ratio as the number of sulfur atoms per CF is known. As listed in 
Table 3.1, CF alone and CF in complex have nearly identical stoichiometries for Ni(II) 
and Co(II), which suggests that metals bind similarly to CF in both cases. Moreover, the 
calculated stoichiometries are both close to one metal ion per CF monomer. In contrast, 
Zn(II) exhibited both a higher and a more variable stoichiometry of 3.9 Zn(II) per CF 
alone and 3.1 per CF in complexes. Thus, for all three metals, we can conclude that a 
large excess (6–12 equiv) is necessary to drive assembly to maximally active CF ternary 
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complexes, but only a fraction of metal is directly involved in the assembly. All further 
studies were done on Ni(II)-assembled samples at 180 µM NiCl2.  
 
Table 3.1. Stoichiometry of metal binding to CF measured by ICP-OES.a 
 
Metal addedb Metal bound to CF 
alonec 
Metal bound to CF in 
complexd 
Ni(II) 
Zn(II) 
Co(II) 
1.2 ± 0.04 
3.8 ± 0.16 
NDe 
1.1 ± 0.05 
3.1 ± 0.12 
1.1 ± 0.15 
aData are averages ± one standard deviation for the number of metal ions bound per CF 
monomer from 10 independent ICP-OES measurements of each metal.  
bMetal added at concentrations found to give maximally active complexes (Figure 3.1, 
arrows).  
c30 µM CF in assembly. 
d30 µM CF, 12 µM CheA, and 24 µM CheW in assembly. 
eCoCl2 with CF alone does not sediment, and thus, metal content could not be measured.  
3.2.3. Receptor His-tag is essential for metal-mediated assembly 
We hypothesized that the His-tag could be involved in the divalent metal-
mediated assembly of functional chemoreceptor complexes, perhaps via stabilization of 
CF dimers or oligomers. To test this, we engineered a variant of the CF construct 
(henceforth called H6CF for the sake of clarity) by inserting the recognition and cleavage 
sequence for TEV-protease after the His-tag (H6TEV-CF). TEV-protease cleavage of 
H6TEV-CF yields ΔH6CF, with the native CF sequence plus a single glycine at the N-
terminus. For each version of CF (H6CF and H6TEV-CF with His-tags, and ΔH6CF with 
no His tag, as shown in Figure 3.3A) we tested the assembly of ternary complexes with 
CheA and CheW by three in vitro methods (vesicles, PEG, and Ni(II)) and measured both 
the kinase activity and protein stoichiometry of sedimented complexes.  
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The three proteins together in buffer with no vesicles, PEG, or divalent metal 
show low kinase activity (Figure 3.3B, None) and <15% sedimentation (Figure 3.2). We 
had previously observed variable levels of kinase activity for H6CF, CheA, and CheW 
assembled in the absence of vesicles, PEG, or added metals, and realized H6CF may 
contain variable amounts of Ni(II), stripped from the NTA-affinity column during 
purification (Sprules et al., 1998). We incorporated a 5 mM EDTA treatment step into all 
purifications, following elution of protein from the column, and this EDTA is removed in 
the subsequent dialysis step. Thus the low level of activity and sedimentation observed in 
the absence of vesicles, PEG, or metal (Figure 3.3B, None) is not due to adventitious 
Ni(II), but presumably reflects the low stability of these complexes formed with the 
truncated CF.  
As shown in Figure 3.3B, both H6CF and H6TEV-CF complexes are functional 
with all assembly methods, indicating that the TEV insertion does not interfere with 
assembly of functional CF complexes. As anticipated, removing the His-tag results in no 
kinase activity and background levels of protein binding for both vesicle and Ni(II) 
assembly methods, demonstrating that the His-tag is required for metal-mediated 
assembly.  
The native stoichiometry of chemoreceptor arrays is thought to be 6:1:2 
receptor:CheA:CheW (Liu et al., 2012; Cassidy et al., 2015). As shown in Figure 3.3C, 
all active complexes of the different constructs assembled with vesicles, PEG, or Ni(II) 
display near-native stoichiometries. The variation in CheW (ranging from 2.1 to 3.0) may 
be due to weak staining of CheW resulting in less accurate quantification. Overall, the 
stoichiometries are consistent with the native-like architecture of PEG arrays, which have 
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high CheA occupancy observed by electron cryotomography (Briegel et al., 2014a). Thus 
PEG mediates assembly via molecular crowding that does not require the His-tag; both 
vesicle and Ni(II) assembly require the His-tag to mediate assembly of complexes with 
comparable kinase activity and protein stoichiometry.   
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Figure 3.3. The His-tag is required for metal-mediated assembly. (A) Cartoon depicting 
constructs tested to determine the role of the His-tag (H6, red box) in metal-mediated 
assembly of active complexes. (B) Specific activity of CheA kinase assembled with 
CheW and His-tagged receptor (black for H6CF or gray for H6TEV-CF) or non-His-
tagged receptor (striped for ΔH6CF). Activities are averages of four to eight replicates 
measured on two to four days; error bars indicate ± one standard deviation. (C) 
Stoichiometries for active complexes determined as the ratio of proteins in the 
sedimented complexes. The ~25–28 µM sedimented CF was set to 6 for calculations of 
the relative amounts of bound CheA (blue) and CheW (cyan), based on ratios of band 
intensities in SDS-PAGE of sedimented complexes. Horizontal solid and dashed lines 
correspond to native 6:1:2 molar stoichiometries. Stoichiometries are averages of two to 
four replicates measured on two to four days; error bars indicate ± one standard 
deviation. Error bars are either large or missing for CheW stoichiometries in PEG 
complexes, due to gel distortions from PEG in the CheW molecular weight range. 
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017 
American Chemical Society. 
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3.2.4. Metal-mediated complexes form native-like arrays  
Chemoreceptor complexes with CheA and CheW form an extended lattice of 
hexagonal arrays located within the bacterial inner membrane that is responsible for 
ensuring a sensitive and integrated response to chemical gradients. Because ternary 
complex formation and kinase activity have been observed in the absence of arrays, 
(Boldog et al., 2006; Swain et al., 2009; Greenswag et al., 2015) we used electron 
cryotomography (ECT) to assess the structural features and homogeneity of the metal-
mediated complexes.  ECT images of both Ni(II)- and Zn(II)-mediated H6CF ternary 
complexes prepared under conditions leading to maximal activity reveal clear high-
contrast hexagonal lattices (Figure 3.4A and Figure 3.5). ECT results show that Zn(II)-
mediated complexes are less abundant and the patches are smaller compared to Ni(II) or 
PEG. This may be due to less rigorous optimization for Zn(II) assemblies. Perhaps excess 
Zn(II) incorporation into the proteins (3–4 Zn per H6CF compared to 1 Ni per H6CF, 
Table 3.1) may somehow perturb extended array formation. Despite their small size, 
subvolume averaging for Zn(II) complexes was still achieved. With 12 nm center-to-
center spacing between hexagons, both metal-mediated arrays are indistinguishable from 
in vivo arrays and from our other in vitro assemblies formed with templating-vesicles and 
PEG-mediated crowding (Briegel et al., 2014a). Interestingly, metal-mediated arrays also 
form the sandwich-like structures seen with PEG (Figure 3.4B). This architecture is likely 
necessary to stabilize the membrane-proximal ends of the long CF in the absence of 
organization by a membrane.  
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Figure 3.4. Ni(II)-mediated functional complexes form native-like arrays. Tomographic 
slices of (A) Ni(II)-mediated H6CF and (B) PEG-mediated H6CF show both top down 
patches of hexagonal arrays (white arrows) and side view sandwich-like structures (black 
arrows) made from two layers of CF with overlapping N- and C-termini that are 
sandwiched between baseplates of CheA and CheW on the outside. Scale bars are 50 nm, 
and insets show enlarged subvolume averages of the hexagonal array with the canonical 
12 nm center-to-center spacing (dotted lines in A and B insets are 12 nm) that is identical 
to in vivo arrays (Briegel et al., 2012, 2014a). Reprinted (adapted) with permission from 
(Haglin et al., 2017). Copyright 2017 American Chemical Society. 
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Figure 3.5. Zn(II)-mediated complexes form small native-like arrays. Tomographic slice 
showing Zn(II)-mediated H6CF ternary complexes assembled under maximally active 
conditions. Native-like hexagons (white arrows) with 12 nm center spacing and side view 
sandwich architecture (black arrows) indicate similar structural features as Ni(II) and 
PEG arrays. Scale bar is 50 nm. Inset shows subvolume average of single hexagons; scale 
bar is 10nm. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 
2017 American Chemical Society. 
 
To further investigate the structural similarities between arrays assembled by 
these methods, we measured the baseplate distances between CheA/CheW layers for 
three assemblies that formed sandwiches. Figure 3.6, a plot of the intensity of the 3D 
volume of the side view for Ni(II)-mediated H6CF, PEG-mediated H6CF, and PEG-
mediated ΔH6CF sandwiches (examples in left panels of Figure 3.6), reveals identical 
distances of 33 nm between baseplates. Given an approximate H6CF receptor length of 
~21.8nm (145 residues, assuming all alpha helical) from the N-terminus to the 
membrane-distal tip, a 33 nm sandwich thickness (Figure 3.6) predicts that CF’s from 
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each side of the sandwich overlap with each other in the central ~10.6 nm region. This 
may be consistent with the disorder (low electron density) observed in the central ~1/3 of 
the sandwich, as seen in a side view of the isosurfaces of electron density calculated by 
subvolume averaging of tomograms for Ni(II) and PEG-mediated H6CF (Figure 3.7). 
Remarkably, the similarity in baseplate distances indicates that the overlap interactions 
that stabilize the sandwich assembly do not depend critically on what stabilizes the 
complexes (metal or PEG) or on the sequence of the N-termini (H6CF vs. ΔH6CF) that 
are present in the overlap region. Ultimately, the similarity in the architecture of the PEG-
assembled H6CF and ΔH6CF arrays indicates that the ECT resolution is not sufficient to 
detect whatever differences in structure and dynamics account for the 2-fold difference in 
kinase activity (Figure 3.3B) between these samples.  
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Figure 3.6. Estimating baseplate distances using tomographic 3D volume intensities. 
(Left panels) Five individual sandwiches for Ni(II)-mediated H6CF (red), PEG-mediated 
H6CF (blue), and PEG-mediated ΔH6CF (green) ternary complexes were selected and 
centered at the identical 3D dimension. For each sandwich structure, 20 slices 
(corresponding to 7 nm of depth) were integrated into one image to enhance the contrast. 
Intensities for each image were measured based on the gray value and plotted along the 
distance measured in pixels (right) in ImageJ. The dip in intensity corresponds to the 
baseplates composed of CheA and CheW, revealing identical sandwich lengths of 33 nm 
for all samples. Scale bars are 20 nm. Reprinted (adapted) with permission from (Haglin 
et al., 2017). Copyright 2017 American Chemical Society. 
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Figure 3.7. Ni(II) and PEG assembled H6CF complexes have similar electron densities 
that overlap with native chemoreceptor arrays. Isosurface representation for H6CF 
assembled with Ni(II) (isosurface in yellow for panel A and B) or PEG (isosurface in 
purple for panel C and D). The cyan mesh represents the density of in vivo hexagonally 
packed chemoreceptor arrays from E.coli (EMDB ID: 2158) (Briegel et al., 2012). Side 
view shows sandwich architecture for two layers of trimers-of-dimers (B, D). Top down 
view (A, C) show two layers of receptor hexagons illustrating that trimers of dimers are 
vertically aligned in the sandwich. In both Ni(II) (A) and PEG (C) samples, the 
hexagonal packing of receptors closely fit with the electron density map of the native 
intact chemoreceptor array. Overlay of maps was done manually in Chimera; density 
thresholds were chosen to highlight the receptor array similarity between different arrays. 
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017 
American Chemical Society. 
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3.2.5. Receptors dimerize and oligomerize with metal 
The results presented above suggest that metal binds to the His-tag of H6CF and 
somehow stabilizes formation of the functional, native-like array with CheA and CheW. 
Within the native architecture, what interactions could be stabilized by metal bridging 
two His-tags? The N-terminal His-tags are likely to be near each other within the H6CF 
dimer. In contrast, His-tags on two different dimers are not adjacent in the trimer-of-
dimers (as shown in Figure 3.8A, they are ~50 Å apart in the ECT-derived structural 
model, Protein Data Bank entry 3JA6 (Cassidy et al., 2015)) and His-tags on the two 
H6CF layers are not likely to be adjacent in the sandwich (they are on opposite sides of 
the ~10 nm overlap region, Figure 3.8B). Thus, it seems likely that metal binding bridges 
two His-tags within a H6CF dimer, and stabilization of the dimer drives assembly of the 
functional array. To investigate this, we monitored the formation of metal-mediated 
complexes of H6CF using size exclusion chromatography coupled with multi-angle light 
scattering (SEC-MALS).  
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Figure 3.8. Approximate His-tag-to-His-tag distances in chemoreceptor structural 
models. (A) In the ECT-derived model containing the Thermatoga maritima receptor 
trimer of dimers (PDB code 3JA6 (Cassidy et al., 2015)),  the residues corresponding to 
the end of the CF His-tag are shown as red spheres on each monomer. Within a single 
dimer, His-tags are 10–15 Å apart, while across the trimer interface can be from 50–65 Å, 
depending on the rotation of the helices. (B) Another structural model was made by 
docking the E. coli serine receptor dimer (PDB 1QU7 (Kim et al., 1999)) into ECT 
density of sandwiched PEG arrays. In this model, the His-tags (red spheres) are more 
than 80 Å apart across the receptor membrane proximal overlap region. Coordinates for 
this model were a gift from Ariane Briegel. 
 
Complex formation of H6CF alone provided the best means of assessing the effect 
of metal on the H6CF monomer–dimer equilibrium, because the CF dimer cannot be 
resolved from CheA (see Chapter 4). We anticipate that binding of Ni(II) to the H6CF 
His-tag is similar in the presence and absence of CheA and CheW, because ICP-OES 
indicates 1:1 binding in both cases. As discussed above, incubation of H6CF alone with 
NiCl2 results in sedimentable aggregates. Apparently, these aggregates can become too 
large to pass the 0.22 µm precolumn filter, as the total eluted protein was observed to 
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decrease over the time course of the experiment (Table 3.2). Figure 3.9A shows the 
overlaid chromatograms from the time course series, all scaled to the same total 
integrated peak area. The amount of aggregate lost in the precolumn filter (dashed line in 
Figure 3.9B) was calculated from the decrease in area with each injection. To quantify 
the fraction of monomer, dimer, and oligomer, elution time ranges were set at the points 
of minimum A280 between peaks (Figure 3.9A, gray vertical lines at 10, 11.7, 12.8, and 
15.5 min), and these peak areas were used to calculate the percentage of H6CF in 
monomer, dimer, and oligomer forms (Figure 3.9B).  
 
Table 3.2. Amount of Ni(II)-induced H6CF aggregation increases with time.a 
 
Incubation timeb Total Elution UV 
Peak Area (A.U.)d 
Aggregate (%)e Scaling factorf 
No NiCl2 
<1 minc 
30 min 
1 h 
2 h 
3 h 
4 h 
0.0268 
0.0260 
0.0214 
0.0174 
0.0144 
0.0127 
0.0079 
0 
3.0 
20.1 
35.1 
46.3 
52.6 
70.5 
1 
1.03 
1.25 
1.54 
1.86 
2.11 
3.39 
 
a30 µM H6CF with 180 µM NiCl2. 
bAliquots were injected from a single large volume sample, to prevent sample-to-sample 
variation, except for a separate “No NiCl2 ” sample of 30 µM H6CF alone. 
cThe minimum amount of time required to add NiCl2 to H6CF and inject it onto the SEC.  
dMeasured across total elution time (10–15.5 min) using ASTRA VI.  
eCalulated as (1–[(Total Peak Area)/(“No NiCl2” Total Peak Area)])×100. Data also 
plotted in Figure 3.9B. 
fCalculated as (“No NiCl2” Total Peak Area)/(Total Peak Area). Used to scale 
chromatograms presented in Figure 3.9A.  
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SEC-MALS of H6CF incubated with 180 µM NiCl2 (Figure 3.9) demonstrates 
that Ni(II) stabilizes the H6CF dimer. Prior to the addition of NiCl2, the monomer:dimer 
ratio is approximately 10:1 (Figure 3.9, red) based on the integrated UV peak area ratio 
of 5.1:1 (area of the dimer peak divided by two gives dimer concentration). Strikingly, 
within the minimal time to add metal to the protein and inject it onto the column (<1 
min), there is a significant decrease in the monomer:dimer ratio to 3.7:1 (Figure 3.9, 
orange), which corresponds to a 2.7-fold decrease in this ratio. At remaining time points, 
both monomer and dimer concentrations continue to decrease in parallel, due to a 
significant increase in the aggregate fraction (Figure 3.9B, Table 3.2). The system is not 
at equilibrium, but the monomer to dimer ratio remains in the range of 6–8:1, consistent 
with Ni(II) stabilization of H6CF dimers. 
 
Figure 3.9. Ni(II) stabilizes the H6CF dimer, which in turn favors larger oligomers. (A) 
SEC-MALS chromatograms of 30 µM H6CF incubated with 180 µM NiCl2, colored by 
rainbow according to the increasing incubation time. Vertical lines indicate elution time 
bounds used to distinguish the monomer (12.8–15.5 min), dimer (11.7–12.8 min), and 
oligomers (10–11.7 min).  Although identical volumes (75 µL) of the same sample were 
injected, some H6CF aggregate was caught in the precolumn filter. Chromatograms are 
scaled to the same total area to account for aggregated protein (B, dashed line). (B) The 
peak areas of the monomer (circle), dimer (triangle), and oligomers (square) were used to 
calculate the amount of H6CF in each state for all incubation times. The percent H6CF in 
aggregates larger than the 0.22 µm pre-column filter (dashed line, listed in Table 3.2) was 
calculated from the loss of area under the SEC elution curve. Reprinted (adapted) with 
permission from (Haglin et al., 2017). Copyright 2017 American Chemical Society. 
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3.2.6. Ni(II) promotes partially reversible H6CF aggregation and fibril formation 
Chemoreceptors have been observed to form alternate non-native structures in the 
absence or with insufficient quantities of their cytoplasmic binding partners, CheA and 
CheW. In particular, so-called “zippers” with interdigitation of the receptor cytoplasmic 
tips have been reported for overexpressed receptors in vivo (Lefman et al., 2004; Zhang et 
al., 2007), reconstituted intact receptors (Weis et al., 2003), and CF assembled on 
templating vesicles (Montefusco et al., 2007). A more detailed analysis of the 
overexpressed intact receptors revealed hexagonal packing with 9 nm center-to-center 
spacing that is distinct from that of the wild-type 12 nm arrays observed in both 
membrane-bound and sandwich architectures (Briegel et al., 2014a). Thus we expected 
that the Ni(II)-induced aggregation in the absence of CheA and CheW would produce a 
similar zipper-like structure. Instead, ECT images (Figure 3.10A) demonstrate these 
conditions yield a mixture of nonspecific aggregates and fibrils with uniform 7 nm widths 
but varying lengths (40–105 nm). Therefore we have identified yet another structure 
formed by CF in the absence of CheA and CheW: double-stranded fibrils. Interestingly, 
these fibrils and aggregates are at least partially reversible: addition of CheA and CheW 
after pre-incubation of H6CF with NiCl2 can produce complexes with kinase activity that 
is 80% of that of normal complexes assembled by adding NiCl2 last (Figure 3.10B).  
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Figure 3.10. Ni(II) promotes partially reversible H6CF aggregation and fibril formation. 
(A) Tomographic slice shows that H6CF incubated with NiCl2 without CheA or CheW 
forms non-specific aggregates (black arrows) and double-stranded fibrils (white arrows) 7 
nm in width. Scale bar is 50 nm. (B) Onset of kinase activity comparing normal assembly 
to pre-incubation of NiCl2 with H6CF before assembly reveals that aggregation induced 
by pre-incubation is partially reversible. For normal assembly (filled circles), 180 µM 
NiCl2 was added last to initiate assembly. Pre-incubation (open circles) of NiCl2 with 
H6CF for 15 minutes was done prior to addition of CheA and CheW to initiate assembly. 
Activities are averages of four replicates measured on two days; error bars indicate ± one 
standard deviation. Pre-incubation activity is plotted as % of maximum normal assembly 
activity on the same day. Reprinted (adapted) with permission from (Haglin et al., 2017). 
Copyright 2017 American Chemical Society. 
3.2.7. PEG and metal promote assembly of CF4E kinase-off state 
The CF4E version of the aspartate receptor has four glutamic acid residues, as 
does the native non-methylated state. It forms complexes with CheA and CheW when 
assembled on vesicles, but crowding of the complexes is needed to force CF4E into a 
kinase-on state (Besschetnova et al., 2008). CF4E also does not form arrays under PEG-
mediated assembly conditions (no significant sedimentation or kinase activity). The 
sandwich architecture of metal and PEG assemblies places the added charge of the 
glutamic acid in CF4E in the overlap region thus, effectively doubling the negative 
charge in that region. Thus electrostatic repulsion is likely to hinder formation of 
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sandwich arrays. However, we observed significant sedimentation of CF4E (63%) under 
conditions for Ni(II)-mediated assembly of complexes. On the other hand, only 11% 
sedimentation occurs in the absence of CheA and CheW, presumably because 
electrostatic repulsion opposes the metal-induced aggregation observed for CF4Q. Since 
Ni(II) and PEG promote assembly of sandwiches by different mechanisms, we 
hypothesized that combining NiCl2 and PEG together would increase the level of 
complex formation and that the resulting complexes would be in the kinase-
off/methylation-on signaling state. 
To test these hypotheses, we prepared complexes of CF4E with NiCl2 or NiCl2 + 
PEG and measured the both kinase activation and methylation (Figure 3.11; methylation 
upon incubation with CheR and SAM results in a gel shift due to faster migration). Both 
conditions yielded sedimentable complexes with native-like stoichiometries (Table 3.3). 
To assess the signaling state of these complexes, we compared their kinase and 
methylation activities to those of NiCl2-assembled CF4Q complexes representing the 
kinase-on/methylation-off state and vesicle-assembled CF4E.A411V (Ames and 
Parkinson, 2006) representing the kinase-off/methylation-on state. Remarkably, all CF4E 
complexes exhibit some degree of methylation and no kinase activity, leading us to 
conclude they are in the kinase-off/methylation-on state.  
Importantly, the methylation assay (gels shown in Figure 3.11B and C) was done 
on the full assembly sample and thus reflects methylation of both complexed and free 
CF4E. Free CF4E is not significantly methylated, as previously shown (Shrout et al., 
2003) and as indicated by the results for Ni(II)-assembled CF4E in the absence of CheA 
or CheW (predominantly free, since only 11% sedimentation, and only 9% of total CF 
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methylated after 4 h). We therefore assumed that all methylation occurs on the 
complexed CF4E and report the %methylated-CF divided by the % sedimented-CF in 
Table 3.3 to indicate the percent methylation of complexed CF4E under each assembly 
condition. As hypothesized, the addition of PEG to NiCl2 improves complex formation 
(63% sedimentation with NiCl2 versus 93% for NiCl2 + PEG), but it is possible that the 
higher CF4E concentrations used for the PEG assembly may account for the some of the 
increase in complex formation. The total methylation of CF4E complexes at 4 hours is 
comparable (80-90%) for all of the metal assembly conditions. There are differences in 
the methylation at 0.1 hour, which may reflect a difference in methylation rates; 
additional experiments and controls are needed to investigate this possibility.  
 
 
Figure 3.11. NiCl2 and NiCl2 + PEG promote assembly of CF4E in the methylation-on 
and kinase-off state. Kinase activity (A) and methylation (B, C) of CF4E assembled 
under various conditions. Control samples are NiCl2-assembled CF4Q for the kinase-
on/methylation-off state, vesicle-assembled CF4E.A411V for the kinase-off/methylation-
on state. An additional control for the methylation assay is NiCl2 CF4E (–SAM, s-
adenosyl-L-methionine) that lacks the substrate for methylation. All CF4E complexes 
assembled with NiCl2 (with or without CheA and CheW) and NiCl2 + PEG exhibit little 
to no kinase activation (A) but do show methylation in the gel shift assay (C, quantified 
in Table 3.3). Gels (B, C) were cropped to show only CF, methylated-CF (meth-CF), and 
CheR for clarity.  
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Table 3.3. Sedimentation, stoichiometry, and % methylation of CF4E complexesa 
 
Assembled Complexb  Sedimented 
CFf Stoichiometryg 
Methylated-CF 
(%)i 
CF (µM) Methode A/W µM % 0.1 h 4 h 
4Q 
4E.A411V 
4Ec 
4E 
4Ed 
Ni(II) 
Vesicle 
Ni(II) 
Ni(II) 
Ni(II) + 
PEG 
+ 
+ 
– 
+ 
+ 
 25.6 
27.7 
3.2  
19.0 
46.6 
85 
92 
11 
63 
93 
6:1.5:3.5 
6:1.1:1.9 
N/Ah  
6:1.4:2.8 
6:0.9:2.1 
N/A 
11 
9  
 26 
 44 
N/A 
75 
80j 
 81 
 90 
 
aCorresponding kinase and methylation data presented in Figure 3.11. 
bProtein concentrations 30 µM CF, 12 µM CheA, and 24 µM CheW, except as noted.c,d 
cNo CheA or CheW present in this 30 µM CF4E sample. 
dSample contains 50 µΜ CF, 12 µM CheA, and 20 µM CheW. 
eNi(II)-mediated complexes contain 180 µM NiCl2; Vesicle-mediated complexes contain 
725 µM lipid (290 µM DOGS-NTA-Ni2+ and 435 µM DOPC); Ni(II) + PEG-mediated 
complexes contain 180 µM NiCl2, 7.5% w/v PEG8000, and 4% w/v D-trehalose. 
fQuantified from sedimentation assay (see section 2.4.2). 
gCalculated stoichiometries of CF:CheA:CheW from pellet lane ratios in sedimentation 
assay (see section 2.4.2). 
hNot applicable as no CheA or CheW is present. 
iQuantifed from gel shown in Figure 3.11. %Methylated-CF = [(Imeth-CF)/( ICF + Imeth-CF)]/ 
%Sedimented-CF. 
jCorrected values indicate the sedimented free CF4E is predominantly methylated, but it 
accounts for only 9% of the total CF4E.  
 
The sandwich architecture exhibited by PEG and Ni(II)-mediated arrays have thus 
far only been observed for CF4Q arrays. Is it possible for CF4E assembled with Ni(II) 
and PEG to retain the sandwich architecture despite electrostatic repulsion? To answer 
this, we returned to ECT to image Ni(II) + PEG-mediated CF4E arrays. Previous ECT of 
CF4E was limited to vesicle-assembled arrays, which tend to have lower resolution due 
to vesicle curvature (Briegel et al., 2014a). Ideal chemoreceptor candidates for ECT are 
thin, flat, and highly ordered (Briegel and Jensen, 2017). 
  59 
While the high concentrations of PEG led to thicker blots on the ECT grids (Wen 
Yang, personal communication), the first look at Ni(II) + PEG-mediated CF4E 
complexes (Figure 3.12) clearly indicates the presence of sandwich arrays that retain the 
12 nm hexagonal array spacing. Unfortunately the collected tomograms show a tendency 
of these arrays to form thick clumps that lack enough order to assign specific structures. 
Moreover, an error in data acquisition may have contributed to lower quality tomograms 
(Wen Yang, personal communication). However, a few small yet distinctive structures 
were visible, including a single hexagon (Figure 3.12A, B) and a sandwich (3.12C).  
 
 
Figure 3.12. CF4E assembled with Ni(II) and PEG exhibit hexagon and sandwich 
architecture. Tomographic slices show predominately low-order aggregation due to PEG 
and non-ideal experimental conditions with the exception of a single hexagon cluster 
(white arrow in A that is zoomed-in in B) and a sandwich structure (C) from elsewhere in 
the tilt series. Scale bars indicate 50 nm in A and 20 nm in B and C.  
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This newfound ability to image CF4E in sandwiches provides a unique 
opportunity to investigate structural changes of signaling and receptor methylation state 
in the context of the array. For example, how does the disordered region observed for 
CF4Q (Figure 3.7) compare to CF4E? Does the added electrostatic interaction alter the 
structural stability in the predominately disordered membrane proximal region? 
Additionally, the ligand-induced expansion model predicts this region would exhibit the 
largest conformational change in which the trimers of dimers are spread farther apart in 
the kinase-off/methylation-on state (Sferdean et al., 2012). Until now, preparing CF 
complexes in this signaling state were limited to: (1) CF4E on low-density vesicles, (2) 
CF4E.A411V on high-density vesicles, or (3) CF4Q.A411V on high-density vesicles, 
PEG, or metal. It’s been shown that vesicle assemblies are limited in resolution due to 
curvature, so we imaged CF4Q.A411V on PEG or metals to probe the structure of the 
kinase-off/methylation-on state. Unfortunately no measureable differences were observed 
compared to CF4Q (data not shown). Recent work from Briegel and coworkers reported 
no conformational changes for various signaling-related mutants of the Tsr receptor, but 
did observe distinct differences in the associated CheA density, particularly for locked-
off mutants (Briegel et al., 2013).  
Moving forward, we propose that investigating the structure, disorder, and CheA 
density of CF4E arrays assembled into sandwiches in the kinase-off/methylation-on state 
may provide new insights into signaling mechanism. However, we note that experimental 
conditions will need to be optimized to minimize thickness on ECT grids (perhaps by 
decreasing PEG concentrations) and to maximize array size (perhaps by increasing PEG 
or protein concentrations). Alternatively, CF4E with Ni(II) alone avoids PEG, but further 
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optimization may be needed to fully form sedimentable complexes as current conditions 
only obtain 63% complexation (Table 3.3).  
3.2.8. Metal-assembled complexes are stable after removing metal 
We have demonstrated that metal-mediated assembly involves metal binding to 
the His-tag to stabilize CF dimers. Assuming excess metal is needed to drive the metal 
binding equilibrium, can the metal be removed without disrupting the array? To 
investigate this, we monitored activity and complexation over time of Ni(II)-mediated 
H6CF complexes following the addition of the metal chelator EDTA. Ni(II) has a much 
higher affinity for EDTA than for hexahistidine-tags on proteins [EDTA KD ≈ 4×10–19 M, 
6His-tagged protein KD ≈ 10–6 M (Knecht et al., 2009)]. Therefore, we assume that 
adding stoichiometric EDTA (180 µM) will chelate the 150 µM unbound Ni(II) (180 µM 
total Ni(II) – 30 µM H6CF-bound Ni(II)) immediately. It’s unclear, however, how 
quickly the Ni(II) bound to H6CF will be removed by the EDTA. To limit dilution 
effects, a small amount (2.5% of the total complex volume) of a highly concentrated 
EDTA stock was added to assembled Ni(II)-mediated complexes. We then measured the 
kinase activity and sedimentation after 30 min, 2 h, and 24 h, all kept at 25°C (Figure 
3.13).  
Remarkably, Ni(II)-mediated complexes do not immediately fall apart following 
the addition of EDTA. In fact, complexes remain 90% intact after 2 h, and ~70% after 24 
h (Figure 3.13B), suggesting the arrays are kinetically stable. Perplexingly, we see a 
larger decrease in kinase activity: 88% activity was retained after 2 h, which dropped to 
46% after 24 h. Without the addition of EDTA, metal-mediated arrays are ~90% active 
after 4 days, but this long-term stability may partially be a result of storing the complexes 
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at 4°C (not shown). Combined, these results suggest that metal removal causes both a 
loss of complexes and a decrease in activity of the remaining complexes.  
Our results clearly indicate the arrays are kinetically stable for a few hours once 
assembled. We cannot, however, distinguish whether these are metal-bound complexes 
(if metal does not immediate dissociate) or metal-free complexes (EDTA strips out metal 
faster than complex dissociation). In the case of metal-free kinetically stable complexes, 
this suggests that arrays can be stabilized by protein–protein interactions alone. 
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Figure 3.13. EDTA causes slow disassembly and loss of kinase activity of Ni(II)-
mediated H6CF complexes. Total kinase activity (A) and sedimentation (B) was 
measured 30 min, 2 h, and 24 h following the addition of 180 µM EDTA to Ni(II)-
assembled complexes and incubated at 25°C. Activity and sedimentation data are 
normalized to the Ni(II) control sample prior to addition of EDTA (total activity of 8.7 s–1 
and sedimentations of 23 µM H6CF, 4.4 µM CheA, and 7.8 µM CheW).    
3.3. Summary and Conclusions 
In this chapter we’ve demonstrated a novel method for triggering assembly of the 
aspartate chemoreceptor cytoplasmic fragment (CF) into nanoarrays through metal-
mediated His-tag dimerization and compared these to other in vitro native-like arrays. 
Functional complexes of CF, CheA, and CheW form upon addition of specific divalent 
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metals and assemble into an extended hexagonal lattice that exhibits the widely 
conserved (Briegel et al., 2009, 2011), native 12 nm center-to-center spacing (Figure 3.4). 
Intact chemoreceptor arrays are normally stabilized by a combination of anchoring in the 
membrane and cytosolic binding of CheA and CheW in rings at the membrane-distal 
cytoplasmic tip of the receptor. In current structural models of the complex, the long 
(~200 Å) cytoplasmic domain has protein–protein interactions with itself, CheA, and 
CheW only at its membrane-distal end, so the constraints imposed by its transmembrane 
and periplasmic domains are likely critical to the stability of the array. The necessary 
membrane-proximal stability to form CF arrays can be achieved with a membrane 
mimetic (templating vesicles) (Shrout et al., 2003) or with a sandwich architecture 
produced with PEG (Fowler et al., 2010) or divalent metals (this work). Importantly, all 
three in vitro preparations with CF yield high CheA occupancy and native stoichiometry 
(Figure 3.3C), although PEG arrays have previously been shown to lack the alternating 
hexagons of CheA observed for in vivo arrays (Briegel et al., 2014a). Measured CheW 
stoichiometries of 2 monomers per 6 CF monomers in these assemblies provide further 
evidence of CheW-only rings that are proposed to provide structural integrity to the array 
(Liu et al., 2012; Cassidy et al., 2015). 
In contrast to the non-native “zippers” that form with cytoplasmic tips 
interdigitated in the center in the absence of sufficient CheA and CheW, “sandwiches” 
have receptors oriented in the opposite direction: cytoplasmic tips interact with 
CheA/CheW rings on both surfaces of the sandwich, forming hexagonal arrays with the 
canonical 12 nm center-to-center packing. Although sandwiches are not the native 
architecture for the E. coli aspartate receptor used in this study, similar cytoplasmic 
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arrays exhibiting both 12 nm hexagonal lattices and sandwich architectures are observed 
for cytoplasmic chemoreceptors (lacking transmembrane domains) from a variety of 
bacteria and archaea, including Vibrio cholerae (Briegel et al., 2016), Rhodobacter 
sphaeroides (Briegel et al., 2014b), and Methanobacterium formicicum (Briegel et al., 
2015). 
The observed metal dependence of assembly is consistent with the proposed His-
tag dimerization mechanism. The relative efficiency of the divalent metals in promoting 
active complex formation, Ni(II) > Zn(II) > Co(II), follows the relative affinities of these 
metals for peptides containing multiple His residues (Sovago et al., 2016). This is 
consistent with preliminary X-ray absorption spectroscopy (XAS) data (Hsin-Ting Huang 
and Michael J Maroney, unpublished observations) suggesting that the Ni(II) bound to 
H6CF is coordinated by 6 ligands, including multiple histidines. Importantly, knowing 
Ni(II) is 6-coordinate and therefore paramagnetic suggests it may be possible to obtain 
distance constraints with paramagnetic relaxation enhancement NMR experiments 
involving comparison to the diamagnetic Zn(II)-assembly that has identical array 
architecture by ECT (Figure 3.5). This could provide critical structural information in the 
overlap region of the sandwich where electron density is lost in ECT (Figure 3.6).  
Assembly of large multiprotein complexes in vitro that retain native structure and 
function is a challenging but essential step in understanding how protein machines 
operate in the cell. His-tag-mediated dimerization is a means of stabilizing protein dimers 
that is much less perturbing than fusion to a protein dimerization motif. For example, 
fusion to a leucine zipper (LZ) introduces 30–60 residues, which is more perturbing than 
a polyhistadine-tag and can interfere with assembly of native complexes. Interestingly, 
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fusion of a 45-residue LZ to the chemotaxis receptor CF used in our study restored kinase 
activation but perturbed the assembly of native complexes with CheA and CheW. The 
LZ-CF assembled into sandwich-like particles in the opposite orientation (two CF layers 
on the outside of a middle layer of CheA and CheW) that prevented formation of the 
native array (Francis et al., 2002, 2004; Wolanin et al., 2006). This comparison of LZ and 
His-tag-mediated dimerization of the same system demonstrates that using the least 
perturbing means of stabilization protein interactions can be critical to assembling native 
complexes. This approach has significant potential for application to other multiprotein 
systems, for the stabilization of functional complexes with native architecture. His-tags 
are widely used and they are easily introduced at many locations within a recombinantly 
expressed protein. This should make it possible to drive dimerization at a known dimer 
interface with minimal perturbation to structure or function, for straightforward and 
accurate in vitro studies of the mechanisms of key processes in the cell. 
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CHAPTER 4 
 
 
INSIGHTS INTO THE MODE OF CHEMORECEPTOR ARRAY FORMATION 
AND KINASE ACTIVATION 
 
This chapter reports on the assembly mechanisms that govern formation of 
hexagonally packed chemoreceptor arrays in complex with CheA and CheW. The metal-
mediated assembly technology (described in Chapter 3) enabled the first experimental 
observation of the early stages of assembly. Most of this chapter was published in the 
article “His-tag-mediated dimerization of chemoreceptors leads to assembly of functional 
nanoarrays” in Biochemistry (Haglin et al., 2017).  
4.1. Introduction 
As discussed in the previous chapter, structure–function analyses of protein 
assemblies in vitro that mimic native systems require a high degree of homogeneity in 
isolating or reassembling such multiprotein complexes. This is particularly challenging 
when proteins must be altered (i.e. truncation or mutation) to facilitate in vitro 
preparations. Moreover, the shear size of large protein assemblies such as chemoreceptor 
arrays can impart an additional challenge to perform accurate and precise biophysical 
studies. However, it remains unclear whether reassembly of the full array is necessary to 
understand the architecture and molecular mechanisms of chemotaxis signal transduction. 
An in vitro reconstitution of intact receptors as trimers of dimers into nanodiscs revealed 
that the core unit involved in the chemoreceptor array is an independent signaling unit 
capable of all chemosensory functions, including ligand binding, transmembrane 
signaling, adaptation modification, and kinase activation/control (Boldog et al., 2006; Li 
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and Hazelbauer, 2011; Li et al., 2011). Additionally, the nanodisc-assembled core units 
contained a stoichiometry of six receptors to one CheA and one CheW. This is at odds 
with the mounting evidence for CheW-only rings seen by ECT (Liu et al., 2012; Cassidy 
et al., 2015), and the stoichiometries we measured for three in vitro native-like arrays (see 
Chapter 3), which indicate native stoichiometry is 6:1:2. Thus, when and how does the 
additional CheW get incorporated into the array if it is not present in the core unit?  
To answer these questions, we must first understand how the array assembles. The 
current model (Liu et al., 2012; Briegel et al., 2014a; Briegel and Jensen, 2017) predicts 
that array formation starts with assembly of trimers of dimers that subsequently form core 
units by binding CheA and CheW. Core units then merge into hexagons that grow into a 
full array through incorporation of additional core units. This model is based on ECT data 
showing the existence of linked trimers of dimers, single hexagons, linked hexagons, and 
patches of hexagons in preparations of isolated native membranes reconstituted with 
overexpressed receptor and excess CheA and CheW. This ECT study did not follow the 
time course of assembly. ECT cannot detect disordered species, including all of the 
separate protein components, and also cannot quantify the ordered species present in a 
sample. A complementary approach is needed to follow the time course of array 
assembly.  
As presented in this chapter, we used our novel metal-mediated assembly method 
to investigate chemoreceptor array formation. Advantages of this method include the 
ability to trigger the assembly in solution and monitor the kinetics of the onset of activity 
and the formation of complexes. Moreover, by eliminating the vesicle and PEG 
components needed for vesicle-mediated and PEG-mediated assembly, we were able to 
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use SEC-MALS to separate and follow the components and complexes, and deduce when 
CheA and CheW are incorporated into the array. Lastly, we correlated the extent of 
kinase activity with array size, leading to a proposal that allosteric effects within the array 
contribute to the overall signaling output. 
4.2. Results and Discussion 
4.2.1. Kinetics of kinase activity and binding 
To understand the mechanism of metal-mediated formation of functional 
complexes, we investigated the assembly kinetics by measuring the onset of kinase 
activity and sedimentation immediately after combining the H6CF, CheA, CheW, and 180 
µM NiCl2. Assembly with either vesicles (Montefusco et al., 2007) or PEG (unpublished 
observations) requires incubation at 25°C for at least 4 h before maximal activity is 
reached. Although the NiCl2 assembly activity similarly achieves maximal activity after 4 
hours (Figure 4.1), the sedimentation profile shows nearly complete binding (80-90%) of 
all three proteins within the first 30 min. Note that complex formation may continue 
during the 30 min centrifugation, whereas the kinase activity measurements take < 2 min; 
therefore complete binding occurs at 30–60 min. Thus, the kinase activity is only 40–
60% when the CheA and CheW incorporation is maximal, which suggests that initially 
the three proteins bind quickly but further changes are needed to reach maximal activity.  
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Figure 4.1. Onset of kinase activation and protein binding of Ni(II)-mediated H6CF 
ternary complex assembly. Time course of kinase activity (black circles) and 
sedimentation of H6CF, CheA, and CheW (black, dark blue, and cyan bars, respectively) 
combined with 180 µM NiCl2. The zero time point is before NiCl2 addition. Activity and 
sedimentation data are normalized to their respective maxima, achieved at 4 h (maximum 
total activity of 7.6 s–1, and maximum sedimentations of 27.0 µM H6CF, 5.8 µM CheA, 
and 13.6 µM CheW). Activities and sedimentation percentages are averages of two 
(sedimentation) and four (activity) replicates measured on two days; error bars indicate ± 
one standard deviation. Reprinted (adapted) with permission from (Haglin et al., 2017). 
Copyright 2017 American Chemical Society. 
4.2.2. Ternary complex and array size increases during assembly 
We returned to SEC-MALS to monitor complex formation with NiCl2. The three 
component proteins and their complexes can be partially resolved via SEC, with the 
largest complexes and proteins eluting first, but SEC does not yield accurate molecular 
weights from variably shaped proteins like the rod-shaped H6CF. The MALS data enable 
the determination of hydrodynamic properties for better estimation of MW. However, 
MW estimation is not accurate for overlapping peaks or high-MW complexes that elute 
near the void volume (10 min on the SEC-MALS used in this study, details in Chapter 2) 
and are highly polydisperse. Separate injections of the individual proteins demonstrate 
they are well resolved and that MALS estimates of the molecular masses are reasonably 
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close to the actual values (Figure 4.2 and 4.3): the 32.7 kDa H6CF elutes at 13.5 min with 
an apparent MW of 34 kDa (black), the 142.7 kDa CheA dimer elutes at 11.5 min with an 
apparent MW of 139 kDa (blue), and the 18.1 kDa CheW monomer elutes at 16 min with 
an apparent MW of 18 kDa (cyan). These proteins were injected at the concentrations 
used for metal-mediated assembly (30 µM H6CF, 12 µM CheA, and 24 µM CheW). The 
H6CF peak observed at 12 min with an apparent MW of 73 kDa (black) corresponds to 
the 65.4 kDa dimer, but is hidden under the CheA peak once all proteins are combined. 
When injected together at the same concentration as the individual injections, ternary 
mixtures exhibit apparent molecular weights uniformly increased by 1.3-fold (Figure 
4.4). It is not immediately clear why all the MW estimates increase, yet the elution times 
exhibit varied changes: CheW elutes faster which is consistent with a MW increase, 
while CheA and CF either don’t change, or elute slower, respectively, neither of which is 
expected for an increase in MW. One possibility is that an increase in peak overlap makes 
MW estimations less reliable.  The two peaks for H6CF and CheW move together 
slightly, which could indicate a possible interaction between the two proteins in solution 
or on the column. There is also a small shoulder at 10.8 min, which is likely to be a small 
amount of ternary complex formation, consistent with the <15% sedimentation observed 
under these conditions for an identical sample (0 time in Figure 4.1, which has no Ni(II)).  
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Figure 4.2. SEC chromatograms of separately injected ternary components. H6CF 
(black), CheA (blue), and CheW (cyan) were injected at concentrations used for assembly 
(30 µM, 12 µM, and 24 µM, respectively), as well as a single injection of all three in 
solution without NiCl2 (red). Molecular masses estimated from multi-angle light 
scattering (MALS) are indicated and are reasonably consistent with the molecular 
weights of dimeric CheA (142.7 kDa), dimers and monomers of H6CF (32.7 kDa), and 
CheW (18.1 kDa). All chromatograms are normalized to a value of 1 for the largest peak 
in the series. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 
2017 American Chemical Society. 
 
 
 
 
Figure 4.3. Accurate molecular masses are estimated from SEC-MALS of individual 
protein injections. Chromatograms for separate 75 µL of each protein at assembly 
conditions (30 µM H6CF, 12 µM CheA, and 24 µM CheW) correspond to data in Figure 
4.2. Molecular weights corresponding to each protein are averages across each elution 
peak. All chromatogram peak heights are normalized to an A280 value of 1 for the CheA. 
Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 2017 
American Chemical Society. 
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Figure 4.4. Apparent molecular mass estimations from SEC-MALS are higher for 
ternary mixtures. As in Figure 4.3, molecular weights corresponding to each protein are 
averages across each elution peak. All chromatogram peak heights are normalized to an 
A280 value of 1 for the CheA. 
 
The first changes observed by SEC during complex assembly involve primarily 
H6CF. The difference between the no NiCl2 and < 1 min with NiCl2 injections (Figure 4.5 
and 4.6, red and orange) is a decrease in H6CF peak height and a corresponding increase 
in the intensity of a high MW species that elutes at 11.1 min. The latter may consist of 
only H6CF oligomers, because there is no significant change in the intensities of the 
CheA and CheW peaks. Next, incorporation of CheA and CheW into complexes with 
H6CF appears to be nearly complete in 30 min, based on both the sedimentation data 
(Figure 4.1) showing nearly complete binding at 30–60 min, and the decrease in the 
intensities of the CheA and CheW SEC peaks (Figure 4.5 and 4.6, yellow) with no further 
changes at longer time points. CheA and CheW are presumably incorporated into a 
complex with H6CF that elutes as a large SEC peak at 11.1 min. While the elution time is 
the same as that of the small shoulder seen immediately after the addition of NiCl2 
(Figure 4.5 and 4.6, orange), this peak is highly polydisperse and thus likely contains a 
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mixture of species with different molecular weights. At longer time points (1–4 h, green 
to blue to violet, Figure 4.5 and 4.6), a second peak emerges at 10.5 min (indicated with 
arrows) at an even higher MW and the H6CF peak continues to decrease to nearly zero 
intensity. These changes coincide with the assembly reaching maximum kinase activity, 
as shown in Figure 4.1. The H6CF, CheA, and CheW peaks remaining at 4 h are 
consistent with the assembly conditions: large amounts of free CheA and CheW because 
these are added in excess, and only ~20% free H6CF, consistent with sedimentation 
analysis that typically shows ~10–15% free H6CF after assembly.  
 
 
 
Figure 4.5. SEC chromatograms of H6CF, CheA, and CheW incubated with NiCl2 reveal 
assembly features. Chromatograms are colored by rainbow according to increasing 
incubation time. A high MW complex of H6CF, CheA, and CheW (11 min elution time) 
that forms in low yield in the absence of NiCl2 (0 min sedimentation in Figure 4.1, and 
red chromatogram also shown in Figure 4.2) and in high yield at early incubation times 
(30 and 60 min in Figure 4.1, yellow & green here) sediments but does not have high 
kinase activity. The arrow indicates a shift to an even higher MW complex eluting at 10.5 
min near the void volume at 10 min elution time.  All chromatograms are normalized to a 
value of one for the largest peak in the series. Reprinted (adapted) with permission from 
(Haglin et al., 2017). Copyright 2017 American Chemical Society. 
 
This experiment was repeated on a second and newer column to test the 
reproducibility of the SEC results. In comparing the series in Figure 4.5 and 4.6, some 
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interesting differences are apparent. Most notably, a shoulder between CheA and H6CF 
that likely corresponds to H6CF dimer can been seen in the new column, indicating 
improved separation. Moreover, it disappears sometime between 1–30 min of assembly, 
which is consistent with rapid dimer incorporation into oligomers (Figure 3.9) and arrays. 
CheA and CheW take longer to fully incorporate (mostly complete after 1 h, with a small 
additional incorporation of CheA at 2 h) compared to binding of CheA and CheW in the 
previous experiment, which was complete after 30 min (Figure 4.5, yellow). Another 
difference is the absence of any complex before the addition of nickel (red), and the fact 
the initial small amount of complex formed at <1 min with little or no CheA and CheW 
(11 min, orange) is resolved from the dominant complex peak at 10.8 min (yellow and 
green).   Finally, the larger complex that appears at long times is better resolved from the 
initial complex (arrows in Figures 4.5 and 4.6), likely due to improved separation on this 
column. While the variations in these results indicate that assembly does not follow an 
identical pathway, it’s clear that CheA/W incorporation occurs prior to assembly of the 
full size extended array. 
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Figure 4.6. Replicate SEC-MALS assembly experiment. Chromatograms of H6CF, 
CheA, and CheW incubated with NiCl2, colored and labeled as in Figure 4.4. The 
proteins were assembled under identical conditions but injected onto a new column, 
resulting in slight variations in elution times. All chromatograms are normalized to a 
value of one for the largest peak in the series. 
 
Lastly we must report an unfortunate reality of the SEC-MALS experiments: for 
reasons that remain unclear, the two SEC columns used for these studies acquired a CF-
specific protease at some point following injection of ternary mixtures. Any variant of CF 
(including CF4E, CF4Q.A411V, H6TEV-CF, and CF4Q prepared by Xuni Li and 
Maryam Kashefi) experienced nearly complete proteolysis on the column and eluted 
predominantly with the buffer components at 22 min. None of the CF variants tested 
exhibited proteolysis in an SDS-PAGE, and were fully capable of forming active 
complexes (data not shown). It is particularly striking that no other proteins experience 
proteolysis. CheA, CheW, BSA, and many other proteins remain completely intact. The 
SEC-MALS is maintained by the Institute of Applied Life Sciences core facility and used 
by many researchers; none have reported proteolysis problems. Future experiments will 
need to avoid SEC-MALS or find a way to prevent proteolysis on a new column.  
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4.2.3. Model of chemoreceptor array formation 
Characterization of the metal-mediated assembly of CF arrays by activity assays, 
sedimentation assays, and SEC-MALS allows us to propose a model for the mechanism 
of this assembly (Figure 4.7) and yields new insights into the assembly and properties of 
native chemoreceptor arrays. The fast (< 1 min) initial increase in the dimer fraction 
(reported in Chapter 3, Figure 3.7) indicates that assembly begins with the stabilization of 
CF dimers, most likely by metals bridging two His-tags. Subsequently CheA and CheW 
are incorporated with metal-stabilized CF dimers into sedimentable complexes. However, 
binding of CheA and CheW is complete within 30–60 min, forming sedimentable 
complexes smaller than the fully active complexes that form in 4 h (Figures 4.1, 4.5, and 
4.6). While our data cannot distinguish the exact size of these initial smaller complexes, 
Figure 4.7 shows one possibility that includes full binding of CheA and CheW into a 
sandwich of two core units, each containing 12 CFs (two trimers of dimers), bridged by 
one CheA dimer, and also containing four CheW monomers. It is unclear what changes 
occur between 1–4 h to yield larger complexes with higher activity that ultimately have 
the canonical hexagonal architecture. In one SEC-MALS series (Figure 4.5) there was a 
small increase in the level of CF binding, while in another series (Figure 4.6) there was a 
small increase in the level of binding of all three proteins. We propose that building to 
larger complexes with maximal activity likely involves assembly of core units into 
hexagons that coalesce to form larger arrays. This final assembly phase also involves 
binding of additional CF, and in some cases of CheA, and/or CheW, to unoccupied sites 
in the coalesced array, as it may include rearrangement of CheA and CheW into the 
native pattern that maximizes CheA binding in alternating hexagons of CheA/W (Briegel 
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et al., 2014a) and only CheW. In any case, it appears that protein–protein interactions 
beyond those in the core unit are required for full activity.  
 
 
 
Figure 4.7. Model of array assembly by Ni(II)-mediated His-tag dimerization. Cartoon 
representation showing progression of assembly starting with CF monomers (side view: 
gray bars and top down: gray circles) rapidly forming dimers upon Ni(II) (black dots) 
binding to CF His-tags (red line). CheA dimers (blue) and CheW monomers (cyan) bind 
to stabilized H6CF dimers to capacity within 30–60 min. Binding of a CheA dimer and 
four CheW drive assembly of a pair of trimers-of-receptor dimers into a core unit, that is 
likely further stabilized as a sandwich. At longer time points (4 h and beyond), the 
assemblies form hexagons and larger arrays with alternating CheA/CheW and CheW-
only rings. Reprinted (adapted) with permission from (Haglin et al., 2017). Copyright 
2017 American Chemical Society. 
4.3. Summary and Conclusions 
In this chapter we used our novel in vitro metal-mediated His-tag dimerization 
method to trigger formation of arrays and investigate the early stages of how these 
proteins assemble into the intricate geometry of the hexagonal array. While the 
architectural features of the fully formed array are known (Briegel et al., 2012; Liu et al., 
2012), the mode of assembly has not yet been clearly established given the difficulty of 
obtaining snapshots in the context of forming the full array. Thus our metal-assembly 
provided a unique and critical opportunity to probe the mode of assembly in vitro. 
Moreover, the insights from this study may shed light on how these remarkable arrays 
form in the cell.  
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Briegel and others (Briegel et al., 2014a) proposed the following model for in vivo 
array assembly: (1) receptors dimerize, (2) three receptor dimers form a trimer of dimers, 
(3) pairs of receptor trimers of dimers are bridged by a CheA dimer and bind two CheW 
to form the core unit, (4) three core units coalesce to form hexagons containing CheA and 
CheW, and (5) the array grows through binding of additional core units or of additional 
CheA/W-filled hexagons. Our data support the importance of the initial receptor 
dimerization in the membrane, since metal-mediated stabilization of the CF dimer is 
sufficient to drive array assembly (Chapter 3). We see no evidence for formation of 
discrete trimers of CF dimers in the absence of CheA and CheW (Lai et al., 2005), and 
instead observe that CF dimers form various oligomers and large aggregates, consistent 
with prior observations in vivo (Zhang et al., 2007). We propose that in the absence of a 
stabilizing membrane or membrane mimetic, CheA and CheW are required to mediate 
assembly of receptor dimers into trimers of dimers. These are then bridged by CheA 
dimers into core units that also bind four CheW. This would satisfy all of the receptor 
binding sites (2 receptor/CheA interfaces, 4 receptor/CheW interfaces, and 6 
receptor/receptor interfaces) and thus prevent non-native interactions that lead to 
aggregation both in vitro and in vivo. Our data support incorporation of 4 CheW into the 
core unit because there is little additional CheW binding upon assembly of larger arrays 
(Figure 4.4). Two of the four CheW in the core unit are weakly bound (lacking the 
CheA/CheW protein-protein interaction), and thus would likely be lost during 
purification of core complexes with full-length receptors in nanodiscs (Li and 
Hazelbauer, 2011) (which contained two CheW per core unit). These weakly bound 
CheW are more likely to be retained under excess CheW conditions as in our CF 
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assembly conditions. It seems likely that the additional two weakly bound CheW in the 
core unit would increase the rate of assembly and, as previously suggested (Liu et al., 
2012), increase the stability of the array. Finally, we propose that assembly of core units 
into hexagons is required to achieve maximal kinase activity.  
Several important differences are expected between the His-tag mediated 
assembly of arrays of receptor fragments and in vivo assembly of membrane-bound 
chemoreceptor arrays. Studies of assembly of CF arrays cannot provide insights into the 
effects of the missing periplasmic, transmembrane, and HAMP domains, or the effects of 
ligand binding (Li and Weis, 2000). Assembly of core units, hexagons, and arrays likely 
occurs faster in vivo due to alignment of receptors in the membrane facilitating 
encounters by 2D diffusion within the plane of the membrane rather than by 3D 
diffusion. Interestingly, although the cellular concentrations of the E. coli chemotaxis 
array proteins have been shown to vary significantly with strain and growth conditions, 
the protein ratios in the cell remain consistent at 2.9 receptors to 1 CheA to 1.2 CheW (Li 
and Hazelbauer, 2004). This excess CheA and CheW is similar to the conditions of our 
His-tag mediated assembly of CF arrays, containing a ratio of 2.5 CF to 1 CheA to 2 
CheW. Although in vitro assembly does not duplicate the crowded conditions in the cell 
that alter protein diffusion rates and affinities, it may be possible to investigate whether 
excess CheA and CheW promote assembly as previously suggested (Briegel et al., 
2014a).  
In conclusion, we have demonstrated that kinetic analysis with this new assembly 
method provides the first experimental evidence that initial binding of CheA and CheW 
into ternary complexes proposed to be the “core unit” does not yield high activity, and 
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that activity reaches its maximum upon formation of larger arrays. His-tag mediated 
dimerization provides a new approach to trigger assembly of native-like chemoreceptor 
complexes that avoids the use of PEG and vesicles which interfere with SEC-MALS 
analysis. This novel assembly method may prove useful for kinetic analysis of the 
assembly of other multi-protein complexes. 
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CHAPTER 5 
 
 
DESIGN AND CHARACTERIZATION OF PARAMAGNETIC RELAXATION 
ENHANCEMENTS FOR LONG-RANGE DISTANCE MEASUREMENTS BY 
SOLID-STATE NMR 
5.1. Introduction 
Transmembrane homodimeric chemoreceptor proteins are responsible for signal 
transmission in bacterial chemotaxis. These predominantly α-helical proteins relay ligand 
binding events from the periplasmic domain to the cytoplasmic subdomains via a 2 Å 
piston displacement of the transmembrane signaling helix that is coupled to the conserved 
HAMP domain (Miller and Falke, 2004; Hazelbauer et al., 2008). The signaling output 
properties of chemoreceptors are characteristic of a two-state model in which kinase-on 
and kinase-off outputs are in an equilibrium that shifts depending on ligand occupancy 
and receptor methylation state. The latter is a mode of adaptation governed by the 
enzymes CheR and CheB that covalently modify receptors at specific sites. Upon high 
levels of methylation, affinity for ligand decreases which restores prestimulus kinase 
activity. It is not yet clear what molecular mechanisms translate the signal through the 
cytoplasmic subdomains to ultimately control the activation or inhibition of the kinase.  
One proposal is that trimers of receptor dimers undergo a conformational change 
upon ligand binding that alters the activity of CheA. Changes in the spacing between 
FRET pairs in the membrane proximal region of Tar and Tsr were correlated to an 
expansion with attractant bound (and subsequent kinase inhibition) and a contraction with 
repellant bound (with kinase activation) (Vaknin and Berg, 2007). Additionally, 
Besschetnova and coworkers observed an apparent receptor density-dependent transition 
between the kinase-on and kinase-off states of receptor cytoplasmic fragments assembled 
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on vesicles (Besschetnova et al., 2008). High density receptor packing would disfavor 
dissociation or expansion, and low density reconstituted intact receptors were shown not 
to dissociate (Sferdean et al., 2012).  Combined, these data led to a proposed model of 
ligand-induced expansion for signal transmission. Given that receptors are anchored at 
their membrane-distal cytoplasmic tips into a lattice of rings of CheA and CheW, this 
model predicts the largest conformational change occurs in or near the membrane due to 
a tilting or straightening of the receptors in the kinase-off or kinase-on state, respectively. 
In light of the findings presented in Chapter 4, we must also consider the possibility that 
the density-dependent activity could be a result of assembly into hexagons. We found that 
kinase activity increases as complexes become larger than the minimal core unit. 
Therefore the proposed low-density, kinase-off state may be smaller units that are widely 
dispersed on the vesicles that coalesce into more functional arrays upon restricting the 
two-dimensional surface area. ECT of such samples has observed some hexagons (Ariane 
Briegel, personal communication), but it is not possible to quantify the fraction of CF that 
forms hexagons vs. smaller core units. Thus, defining the structural features and 
interdimer distances in the membrane-proximal region is needed to test the ligand-
induced expansion model. 
Although significant progress has been made in resolving some structural features 
of chemoreceptors within the array, the membrane-proximal cytoplasmic region remains 
elusive. ECT of intact receptors in vivo and receptor fragments assembled into arrays in 
vitro (including those presented in Chapter 3) all exhibit density at the membrane-distal 
tip of the receptor that gradually disappears closer to the membrane (Briegel et al., 2012, 
2014a; Liu et al., 2012; Cassidy et al., 2015). Consistent with this, Liu and coworkers 
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reported evidence that the receptor assumes multiple conformations in the membrane-
proximal portion, (Liu et al., 2012, supplemental Figure S8). Thus structural restraints in 
the membrane-proximal region of the chemoreceptor are needed, both to constrain the 
dimensions of the trimer of dimers and to test the proposed expansion model by 
comparing arrays assembled in defined signaling states. Such distance constraints would 
clarify whether the effect of assembly density on kinase activity is due to receptor 
expansion/contraction or to a coalescing of core units and hexagons into larger and more 
functional arrays.  
A number of NMR methods are available to measure distances such as NOEs 
(Nuclear Overhauser Effects) and REDOR (Rotational Echo DOuble Resonance). 
However, the techniques are limited to distance measurements ~5–10 Å. A structural 
model of the core unit (PDB 3JA6) predicts that dimers are splayed ~20 Å apart in the 
middle of the methylation subdomain and >60 Å at top of the HAMP domain. Thus we 
sought an alternative approach to measure longer-range distances across the inter-dimer 
interface.  
Paramagnetic relaxation enhancements (PREs) result from dipolar interactions 
between unpaired electron spins and surrounding nuclei. These far exceed internuclear 
dipolar couplings, and can, therefore, affect 15N nuclei up to 20 Å away from the 
electron. Unpaired electrons from nitroxide radicals significantly enhance transverse 
relaxation (T2) of nearby nuclei leading to peak broadening and signal attenuation. In an 
NMR spectrum, PREs to a nitroxide radical are detectable as a decrease in peak 
intensities (cartoon representation shown in Figure 5.1) that is directly proportional to the 
inverse sixth power of the electron–nucleus distance. Therefore, by introducing an 
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unpaired electron at a specific site within the receptor, structural constraints can be 
obtained on a length scale consistent with the distances we aim to probe. 
 
 
Figure 5.1. Nitroxide radicals enhance T2 relaxation, leading to signal attenuation. 
Reduction in peak intensity occurs for resonances in close proximity to a paramagnetic 
center compared to a diamagnetic center. The reduction corresponds to the PRE, which is 
proportional to the electron–nuclear distance by the inverse sixth power. 
 
As shown in Figure 5.2, paramagnetic tags are easily introduced into proteins 
through site-directed spin labeling (Hubbell and Altenbach, 1994a, 1994b) in which a 
thiol-specific label such as the nitroxide radical MTSL [(1-oxyl-2,2,5,5-tetramethyl-Δ3-
pyrroline-3-methyl)methanethiosulfonate] (Berliner et al., 1982) reacts with a unique 
cysteine on the protein of interest. The first section of this chapter describes key features 
of the method and yields of site-directed spin labeling applied to the cysteine mutant 
S487C of the CF4E receptor.  This site was chosen to address a number of criteria: (1) 
S487 is located near the top of the methylation subdomain (Figure 5.3) in order to probe a 
distance anticipated to show the largest measurable change upon the proposed expansion 
(S487 faces the inside of the trimer of dimers, with ~18–20 Å interdimer distance from 
the S487 hydroxyl protein to the backbone, (2) S487 is predicted to be solvent exposed, 
leading to improved labeling efficiency, and (3) S487C has previous been shown to retain 
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60% specific kinase activity and CheA/CheW binding compared to WT CF4E 
(Mudiyanselage et al., 2013).  
 
 
Figure 5.2. Structure of the nitroxide spin label (1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-
3-methyl)methanethiosulfonate (MTSL). Introducing it site-specifically is accomplished 
by reacting with free unique cysteine thiols on a protein. This figure is modified from 
(Jaroniec, 2012).  
 
 
 
 
Figure 5.3. The location of initial spin label site (S487) is shown on the structural model 
of the trimer of dimers. (A) Top down and (B) side view are colored with the N-helix in 
light gray and C-helix in black. The spin label site (red sphere is S487 hydroxyl proton, 
shown on one monomer for clarity) resides near the top of the methylation subdomain 
facing the inside of the trimer of dimers (methylation sites shown as magenta spheres).  
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This chapter presents NMR data comparing spin-labeled and non-spin-labeled 
CF4E assembled on vesicles. Our results confirm that PREs are detectable in our system 
and provide a platform, upon further experimental refinement, to obtain the first 
structural restraints in the membrane-proximal region of chemoreceptors in functional 
and native-like arrays. 
5.2. Results and Discussion 
5.2.1. Spin labeling CF4E.S487C yields 75% efficiency and is non-perturbing 
Site-directed spin labeling typically utilizes an excess of spin label over protein 
(typically 5–20 mol spin label/mol protein) that is subsequently removed by gel filtration 
chromatography or desalting (Hubbell and Altenbach, 1994b). Site-directed spin labeling 
of cysteines competes with formation of disulfide cross-linked protein dimers, which 
cannot be spin labeled. Therefore, an important first step to maximize labeling efficiency 
is to reduce any cross-linked protein prior to the addition of spin label. In solution, 
CF4E.S487C is approximately 40% dimer (Figure 5.4A), but that is reduced to <1% 
following incubation with 2 mM TCEP for 30 min at 25°C. Importantly, TCEP is 
removed immediately before the addition of MTSL, as a reducing environment inhibits 
successful spin labeling.  
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Figure 5.4. Non-reducing SDS-PAGE analysis enables quantification of CF4E.S487C 
dimer fractions. (A) CF4E.S487C in the absence (–) or presence (+) of 2 mM TCEP, 
added after protein purification. As quantified from ImageJ, treatment with TCEP for 30 
min fully reduces all dimers. (B) Removal of TCEP followed by an overnight spin 
labeling incubation at 4°C, U-15N-CF4E.S487C results in ~25% dimer. Gel samples were 
prepared by quenching additional dimer formation with 10 mM NEM and gel sample 
buffer immediately prior to boiling. 
 
 Following optimization, we found that eluting CF4E.S487C from the desalt 
column for TCEP removal directly into a tube containing an excess amount of MTSL led 
to the most monomer retention by SDS-PAGE. Unfortunately, we were unable to 
implement an EPR-based method to measure spin label efficiency, as our results were not 
reproducible. Instead, we used a combined approach: SDS-PAGE was used to quantify 
monomer and dimer fractions, followed by ESI-MS analysis which was used to 
distinguish unlabeled CF monomer from MTSL-labeled CF monomer by mass.  
With the ultimate goal of PRE measurements by NMR, we isotopically labeled 
CF4E.S487C with uniform 15N, prior to MTSL-labeling. As seen in Figure 5.4B, 
approximately 25% dimer is retained following the spin labeling protocol (section 2.8.2). 
ESI-MS analysis of U-15N-CF4E.S487C + MTSL reported a single mass corresponding 
to CF + MTSL, indicating 100% labeling yield of the monomer fraction. We therefore 
conclude a final spin labeling efficiency of 75% was achieved for U-15N-CF4E.S487C. 
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To monitor the effects of spin labeling on protein function, we measured kinase 
activity and assembly (with templating vesicles) of CF4E.S487C before and after 
treatment with MTSL. The results presented in Figure 5.5 clearly indicate normal activity 
and complex formation (shown in 5.5B for MTSL-labeled U-15N-CF4E.S487C).  
 
Figure 5.5.  MTSL-labeled U15N-CF4E.S487C has normal activity and binding. (A) 
Spin-labeled and unlabeled U-15N-CF4E.S487C assembled on vesicles with 6 uM CheA 
and 12 µM CheW exhibit kinase activity similar to typical CF4E activities of ~7 s–1. (B) 
Sedimentation assay with a non-reducing gel shows the total (T), supernatant (S) and 
pellet (P) lanes of the MTSL-labeled complexes from (A). Combined, 75% monomeric 
CF (CFm) and 25% dimeric CF (CFd) are fully incorporated into complexes with CheA 
and CheW at a stoichiometry of 6 CF (monomer + dimer): 1.1 CheA: 1.7 CheW. The 
highest molecular weight band present in T and S lanes may be an impurity, non-
functional CF trimers, or CF + CheA cross-links since CheA contains multiple cysteines. 
However, it not present in complexes, as it is absent in the pellet. Gel samples were 
prepared by quenching additional dimer formation with 10 mM NEM and gel sample 
buffer immediately prior to boiling.  
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5.2.2. Paramagnetic relaxation enhancements (PREs) observed by 1D 15N NMR 
To test for PREs, we assembled spin-labeled and non-spin-labeled U-15N-
CF4E.S487C into complexes with templating vesicles. Figure 5.6 compares the 1D 15N 
cross polarization (CP) spectra of the non-spin-labeled (black) with MTSL-labeled (red) 
complexes. These spectra were collected using identical parameters (see section 2.8.4) 
and the samples notably contain precisely the same amount of CF (286 nmol). The largest 
peak (centered at 121 ppm) corresponds to the bulk of backbone and side chain nitrogen 
signals. However, some resonance assignments were possible for nitrogens with unique 
chemical shifts (Table 5.1).  
The MTSL-labeled spectrum clearly demonstrates PREs, seen as a reduction in 
signal intensities for backbone and some side chain signals. To generate a difference 
spectrum (green), the red spectrum was subtracted from the black spectrum. The intensity 
of the difference spectrum was multiplied two-fold to facilitate visualization, clearly 
showing all positive peak differences. This indicates the MTSL-labeled spectrum has a 
globally lower intensity than the non-labeled spectrum. Notably, the structural model 
predicts that no Lys are within 20 Å of the hydroxyl proton of S487, which is consistent 
with the NMR spectra that show no change in the Lys signal intensity (the difference 
spectrum at 33 ppm is flat). Any free MTSL would presumably cause signal attenuation 
throughout the protein, including some of the 8 Lys located in the methylation and 
signaling subdomains of the receptor.  Thus the observed difference spectrum is 
consistent with PREs caused by the MTSL bound specifically to S487C on CF4E. 
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Figure 5.6. PREs are observed for MTSL-labeled U-15N-CF4E.S487C. The PRE 
difference spectrum (green) between non-MTSL-labeled (black) and MTSL-labeled (red) 
kinase-on arrays is consistent with a decrease in signal intensity due to PREs from MTSL 
bound to S487C. These 1D 15N CP spectra were collected as described in section 2.8.4. 
Resolved nitrogen sidechain and Gly backbone resonances are labeled according to their 
predicted chemical shifts (also in Table 5.1). The inset table lists the number, residue 
type, and interface location of resolvable nitrogen signals predicted to be within 20 Å of 
the hydroxyl proton of S487C. These predictions are from the structural model of the 
trimer of dimers made by docking crystal structures of receptor fragments into PEG-
mediated array EM density (courtesy of Ariane Briegel, and shown in Figure 5.7). 
 
 
Table 5.1. Predicted 15N chemical shifts for α-helix resonancesa 
 
15N Location Ser Thr Asn Gln Gly Arg Lys 
Backbone 
Side chain 
114.8 
- 
115.3 
- 
117.6 
113 
118.6 
112 
107.3 
- 
118.9 
85 (Nε)            
73 (NH1/2) 
119.9 
33 
aResonance assignments based on (Wang and Jardetzky, 2002) 
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Figure 5.7. Predictions of resolved nitrogens within 20 Å of S487C-MTSL. The top 
down view of the structural model illustrates the unique nitrogens near the spin label site 
(red sphere, shown on one monomer for simplicity) including intradimer: Gly (cyan), Arg 
(blue), and Asn (purple), and interdimer: Gln (orange).  
 
The largest signal attenuations observed in the 1D 15N CP spectra (Figure 5.6) 
unsurprisingly occur in the backbone region. As previously mentioned, the closest nuclei 
to the unpaired electron will experience the largest PRE. Beyond backbone nitrogens, 
there are a number of potentially resolvable side chain nitrogens that are predicted to be 
within 20 Å of S487 based on the structural model of the Tar trimer of dimers. Figure 5.7 
illustrates the nitrogens within 20 Å of S487 with unique chemical shifts (Table 5.1). 
Most significantly, there are four Gln Nε (two on each opposing dimer) predicted to be 
18 Å from S487. Since the 1D spectra do not resolve the Gln side chains from Asn (112 
vs 113 ppm), we cannot determine whether the PRE observed for the Gln/Asn peak is due 
to both, or just the intradimer Asn.   
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5.3. Summary and Conclusion 
In this chapter, the feasibility and utility of site-directed spin labeling to obtain 
paramagnetic relaxation enhancements in functional chemoreceptor arrays was 
demonstrated. Using thiol-chemistry, a paramagnetic spin label (MTSL) was successfully 
attached to the unique cysteine S487C of CF4E to a final yield of 75% spin-labeled, as 
measured by SDS-PAGE and ESI-MS. Together, the kinase activity and sedimentation 
data show that spin label incorporation does not perturb function or assembly. 
The NMR spectra obtained for U-15N-CF4E.S487C arrays with and without 
MTSL confirm our ability to detect PREs, which are observed as signal attenuation of 
nuclei in close proximity to the unpaired electron of the nitroxide radical. However, these 
data clearly present a challenge moving forward: the low resolution 1D 15N CP NMR 
limits resonance specificity and sensitivity. Our ultimate goal is to obtain interdimer 
distance restraints in a region of the receptor lacking high-resolution structural 
information. This is particularly difficult given that the magnitude of PREs (i.e. the signal 
decrease) drops at the longer distances we aim to measure (Jaroniec, 2012). Using PREs 
to test the proposed signaling-related expansion (Besschetnova et al., 2008) poses an even 
greater challenge, as it requires comparing difference spectra of samples prepared in the 
kinase-on and kinase-off state. At the long-range distances needed to probe the expansion 
hypothesis, it’s entirely possible the magnitude of PREs is too small to be resolved. 
Therefore, we have devised strategies to improve specificity and sensitivity in order to 
test our models and quantitatively measure interdimer distances.  
We have devised a combined mixed labeling scheme and site-specific NMR 
experiments that will further simplify the observed spectra. This approach involves 
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assembling arrays containing a mixture of cross-linked dimers of U-13C-15N-CF4E.S272C 
and natural abundance MTSL-labeled CF4E.S487C. Cross-linking CF4E dimers at 
S272C (orange spheres in blue dimers of Figure 5.8) prevents dimer exchange and has 
been shown to retain ~80% activity (Mudiyanselage et al., 2013). Therefore, this mixed 
labeling scheme essentially filters out resonances from intradimer PREs given the low 
13C and 15N abundance without isotopic labeling of CF4E.S487C. Importantly, we must 
take into account the distribution of possible trimer of dimer permutations. Assuming a 
50:50 random mixture, 12.5% will contain only natural abundance MTSL-labeled 
CF4E.S487C dimers and 12.5% only isotopically labeled CF4E.S272C. The remaining 
75% will be mixed trimers, split equally between one inner MTSL label per trimer 
(shown in Figure 5.8) and two per trimer. This labeling strategy gives exclusively 
interdimer PREs and can be used to measure distances in 1D spectra, so extensive signal 
averaging will enable us to detect small changes from PREs.  
  95 
 
 
Figure 5.8. Structural model of the trimer of dimers illustrates proposed approach for 
interdimer distance measurements. The mixed labeling scheme involves assembling 
arrays containing natural abundance CF4E.S487C (± MTSL, red sphere) shown in gray 
and black, and U-15N, 1-13C-Val-CF4E.S272C shown in blue (S272C cross-links, orange 
spheres). The unique dipeptide VQ490 (Q490 backbone N shown in yellow) is predicted 
to be 18 Å from the hydroxyl proton of S487C. 
 
While not quantitative at this stage, we have demonstrated measurable PREs to 
MTSL-labeled S487C, probing the membrane-proximal region of the chemoreceptor 
cytoplasmic domain in functional complexes. We have designed a feasible strategy to 
measure quantitative PREs and provide structural constraints in this poorly understood 
region of the receptor. This work has set the stage for future studies aiming to test the 
proposed expansion model of signal transmission.  Moreover, it will define structural 
features of the receptor in the context of the array. It is widely applicable to any site that 
can be mutated to cysteine throughout the receptor, to further constrain the structure.
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CHAPTER 6 
 
 
SUMMARY AND RECOMMENDATIONS 
6.1. Summary of Findings 
The main objective of this study is to probe the functional architecture and 
assembly governing bacterial chemotaxis array formation in order to elucidate molecular 
mechanisms of kinase regulation. To accomplish this, a metal-mediated assembly 
strategy was developed to recapitulate the activity and structure of native chemoreceptor 
arrays using aspartate receptor cytoplasmic fragments (CF). In this method, divalent 
metals including Ni(II), Zn(II), and Co(II) bind to monomeric CF N-terminal His-tags, 
which sufficiently stabilizes receptor dimers to promote ternary complex formation with 
CheA and CheW. Activity measurements show that metals promote kinase-on state 
assemblies of CF4Q, while metals combined with the crowding agent PEG drive 
assembly of CF4E into the kinase-off/methylation-on state. Furthermore, electron 
cryotomography (ECT) show these assemblies retain native-like architecture of the 
canonical 12 nm center-to-center extended hexagonal lattice.  
Metal-mediated assembly has enabled a deeper understanding of the relationship 
between the array and kinase activation. Thus, a number of complementary principles 
emerge from this work. First, we found that receptor dimerization with metal—observed 
by size exclusion chromatography (Figure 3.9)—is sufficient to drive assembly of 
complexes with CheA and CheW. This is consistent with results indicating that cysteine 
cross-linked receptor dimers form sedimentable complexes with CheA and CheW in the 
absence of stabilizing agent such as vesicles, PEG, or metal (Haglin, Li, and Kashefi, 
unpublished observations). We did not, however, observe discrete trimers of receptors 
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dimers by SEC. Instead, dimers form large oligomers, aggregates, and fibrils (Figure 
3.10) in the absence of CheA and CheW. Remarkably, the metal-induced aggregation is 
at least partially reversible; kinase activity is restored to aggregated His-tagged CF upon 
the addition of CheA and CheW. Thus, ternary complex formation is highly favored in 
the presence of metal.  
The second principle that emerges is that allosteric interactions beyond the core 
signaling unit contribute to fully activating the kinase. Kinetic analysis of the metal-
mediated assembly process using kinase activity and sedimentation (Figure 4.1), and SEC 
(Figure 4.5) indicate CheA and CheW fully incorporate into complexes prior to the onset 
of full kinase activity. Moreover, a distinct size shift to larger complexes at later 
assembly times points (1–4 h) coincides with maximal activity. We cannot discern the 
size of the initially smaller complexes, but they are large enough to sediment and clearly 
form prior to assembly of the fully extended array. Since no further CheA or CheW binds 
upon assembly into the extended array and measured stoichiometries are consistently 
6:1:2, we conclude that core units contain four CheW in which two are bound strongly to 
receptor and CheA, and two bound weakly to receptor alone (Figure 4.7). Importantly, 
our results suggesting important allosteric interactions within the array are directly at 
odds with reports that single core units prepared with intact receptors reconstituted into 
nanodiscs are capable of all chemosensory functions to the same degree as native 
membrane-bound arrays (Boldog et al., 2006; Li and Hazelbauer, 2011; Li et al., 2011). 
However, we note that their core units are missing extra CheW due to extensive washing. 
Proposed to provide array integrity as a CheW-only ring (Briegel et al., 2012; Liu et al., 
2012), perhaps excess CheW plays a role in preserving optimal array assembly and 
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symmetry of the alternating CheA/W patterning best observed for in vivo arrays (Briegel 
et al., 2014a). 
Taken together, these outcomes shed light on a correlation between 
chemoreceptor array size, array integrity, and kinase activity. Previously, it was observed 
that the density of CF4E on templating vesicles was coupled to both kinase activation and 
receptor methylation. Concurrently measured FRET efficiencies between receptor C-
terminal tails suggested an expanded or dissociated state at lower receptor density 
(Besschetnova et al., 2008). Additionally, reconstituted intact receptors at multiple 
densities maintained similar ligand affinity, thus ruling out receptor dissociation 
(Sferdean et al., 2012). These data lead to a proposed ligand-induced expansion model 
(Figure 1.4). However, in light of the evidence presented in this study that low kinase 
activity correlates with smaller arrays, we offer an alternative perspective that could 
equally describe the observed activity density dependence: at low densities, receptor core 
units are stably assembled but scattered and activate the kinase with less efficiency; high 
receptor densities exhibit increased kinase activity as a result of achieving a fully packed 
hexagonal lattice. The last section of this study established an approach to test these two 
interpretations. The ligand-induced expansion model predicts the greatest trimer of 
dimers distance change would occur nearest the membrane. As such, we aimed to collect 
long-range structural measurements and constrain the trimer of dimers structure in the 
membrane-proximal region. In comparing kinase-off and kinase-on assembled arrays 
(either by density or mutation), an observed difference in trimer distances would confirm 
an expansion whereas no change in distance would suggest core units are scattered at low 
density.  
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To measure interdimer distances and test the expansion model, we initiated a 
paramagnetic relaxation enhancement (PRE) solid-state NMR approach. The data 
presented in Chapter 5 indicate incorporation of the nitroxide paramagnetic spin label 
(MTSL) at S487C of CF4E yields high labeling efficiency (75%) and does not perturb 
activity or array assembly. Furthermore, a comparison of 1D 15N NMR spectra with or 
without spin label demonstrates PREs consistent with predictions from the trimer of 
dimers structural model. Since quantitative distance measurements were not immediately 
obtainable with a uniform 15N-labeling scheme, we developed proposals to further 
improve our sensitivity and specificity, as discussed in section 5.3.  
6.2. Recommendations 
A number of interesting questions emerge from this study. First, the role of excess 
CheW in core complexes and the extended array remains unclear due to conflicting 
observations. On one hand, Studdert and coworkers reported that overexpressing WT 
CheW or high-receptor affinity mutants of CheW interfered with trimer formation, 
clustering, and chemotactic ability (Studdert and Parkinson, 2005; Cardozo et al., 2010). 
Conversely, Maddock et al. found normal polar clustering of chemoreceptors in the 
absence of CheA, suggesting CheW alone is sufficient to drive assembly of complexes 
(Maddock and Shapiro, 1993). The repeating protein–protein contacts between 
CheA/CheW and CheW/Receptor anchor the three components of the core unit and the 
extended array. These interfaces have been defined through both in vitro (Natale et al., 
2013; Piasta et al., 2013) and in vivo (Pedetta et al., 2014) disulfide crosslinking 
experiments, NMR (Vu et al., 2012; Wang et al., 2012a), and x-ray crystal structures 
(Briegel et al., 2012; Li et al., 2013). In an ECT-derived model, CheW within the CheW-
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only ring interact with adjacent receptors through strong hydrophobic interactions similar 
to those for CheA-P5 to receptors (Liu et al., 2012). Notably absent from the literature, 
however, is a detailed study of the CheW/CheW interactions within the functional array. 
A detailed disulfide mapping of CheW–CheW contacts for arrays would shed light on 
both the type and strength of these interactions.  
We have demonstrated in this study that excess CheW is likely a component of 
the chemosensory core unit and therefore an integral part of the array as CheW-only 
rings. Is it possible that by satisfying all available receptor binding sites, excess CheW 
enhances assembly? One such possibility is that excess CheW helps drive the alternating 
CheA/W and CheW-only ring patterning observed optimally for in vivo arrays (Briegel et 
al., 2014a). We could test this by assembling either PEG or metal arrays with both low 
and high CheW concentrations in the assembly, and analyze the effects on kinase 
activity, assembly (by SEC), and array structure (by ECT).  
While the metal-mediated assembly method has found great use and applicability 
for bacterial chemotaxis arrays, we ultimately feel it will find a greater use in other large 
multiprotein complex systems. Given the extraordinarily crowded conditions of the cell 
(Ellis, 2001), a vast number of important biological processes are performed by protein 
dimers or protein complexes (Alberts, 1998; Marsh and Teichmann, 2015). Fully 
understanding these processes is often accomplished through in vitro recapitulations of 
native systems. Our in vitro strategy is particularly well suited for proteins that dimerize 
as part of their assembly process, such as many other transmembrane signaling proteins. 
The mechanism of metal assembly relies on His-tags, which are widely used and easily 
incorporated into proteins on the termini and within. To conclude, we feel that this work 
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has begun to unravel integral functional and architectural features of chemoreceptor 
arrays, and hope that applying this method to other more complex systems can make 
similar advances.  
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APPENDIX 
 
 
UNILAMELLAR VESICLE ASSEMBLY OPTIMIZATION 
 
Template-directed vesicle assembly of chemoreceptor signaling complexes was 
developed as a simplified approach to study the receptor cytoplasmic fragment (CF) in 
functional complexes with CheA and CheW (Shrout et al., 2003). Mixed lipid vesicles 
containing a nickel-chelating lipid (DOGS-NTA-Ni2+, henceforth called DOGS for 
simplicity) were used to guide the assembly of histidine-tagged CF onto the outer leaflet 
of the lipid bilayer. Preparation of unilamellar vesicles is critical for achieving a known 
membrane surface area that is fully occupied by hexagonally organized active complexes.  
Active signaling complexes form under a variety of lipid and protein concentrations, but 
retaining native-like array hexagonal geometry and protein stoichiometry requires fine-
tuning. To address these issues, this appendix describes (1) the implementation of a 
fluorescence-based assay to measure vesicle lamellarity, and (2) optimization of protein 
concentrations to achieve maximal kinase activation and native-like stoichiometry (6 
CF:1 CheA:2 CheW) on these unilamellar vesicles.  
 
A1. Fluorescence Lamellarity Assay 
 
The preparation of lipid vesicles, as described in Chapter 2 (Section 2.2), includes 
freeze/thaw cycles following lipid rehydration in order to promote formation of 
unilamellar vesicles. Prior to including this in the protocol, our vesicle preparations were 
heterogeneous mixtures of unilamellar, bilamellar, and multilamellar, as seen by ECT 
(Figure A.1).  
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Figure A.1. Tomographic slices of binary lipid vesicles containing DOPC and DOGS-
NTA-Ni2+ show extensive lamellae layering. These multilamellar vesicles (MLVs) were 
extruded to 100 nm (see Chapter 2) but did not undergo cycles of freeze/thaws. ECT 
kindly provided by Dr. Ariane Briegel. 
 
We employed a fluorescence-based assay to monitor the integrity of our vesicle 
preparation and determine vesicle lamellarity (McIntyre and Sleight, 1991; Angeletti and 
Nichols, 1998; Heider et al., 2011). For this experiment, vesicles were prepared as 
described in Chapter 2 (including freeze/thaw cycles) with the addition of the fluorescent 
lipid DOPE-NBD (1,2-dioleoyl-sn-glycero-3-phosphethanolamine-N-(7-nitro-2-1,3-
benzoxadiazol-4-yl) such that the final DOPE-NBD concentration was 1% of the total 
lipid. We assume that the high degree of miscibility of these ternary mixtures of lipids 
(DOGS + DOPC + DOPE-NBD) promotes equally dispersed NBD on the inner and outer 
leaflets. Vesicles were diluted to ~100 µM lipid for a final NBD concentration of ~1 µM, 
and placed in a fluorometer that is setup to perform a time-based experiment (~10 
minutes) with NBD excitation and emission wavelengths at 460 nm and 535 nm, 
respectively. As shown in Figure A.3, the first 200 seconds of recording was sufficient to 
determine initial intensity and photo bleaching effects. Then, the membrane impermeable 
NBD fluorescence quencher dithionite was added to a 1000-fold excess over the NBD 
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(for example, 1 mM dithionite added to 1 µM DOPE-NBD that is at 1% concentration of 
the 100 µM vesicles), and fluorescence levels recorded for an additional 200 seconds. 
The drop in fluorescence was then used to estimate the number of lamellae present in the 
vesicle population. Following quenching, the remaining fluorescence of predominantly 
unilamellar vesicles should be ~50% of the initial intensity, originating from the interior 
bilayers of the vesicles (Figure A.2 and A.3). Quenching to less than 50% of initial 
fluorescence may indicate the presence of leaky vesicles. Quenching to levels between 50 
and 100% may indicate the presence of multilamellar vesicles.  
 
 
Figure A.2. Cartoon representation of outer leaflet quenching of DOPE-NBD. NBD 
labeled lipids are colored in red. Upon addition of dithionite (S2O42–), only inner leaflet 
DOPE-NBD lipids retain fluorescence. Reprinted (adapted) with permission from (Heider 
et al., 2011). Copyright 2011 American Chemical Society.  
 
To solubilize the vesicles, Triton X-100 was added above its critical micelle 
concentration of 0.22 mM (Tiller et al., 1984) and at least a 4-fold excess over total lipid 
concentration (for example, 400 µM Triton X-100 added to 100 µM vesicles). The return 
to baseline fluorescence intensity indicates complete vesicle disruption and full 
quenching of the inner leaflet DOPE-NBD.   
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Figure A.3. Relative fluorescence intensity changes upon outer leaflet quenching. This 
plot of relative fluorescence intensity is from a population of vesicles showing fractional 
intensity loss as a result of quenching the outer leaflet NBD with dithionite. A 100 µM 
solution of 59% DOPC, 40% DOGS-NTA-Ni2+, and 1% DOPE-NBD was placed into a 
cuvette and fluorescence measured over time (excitation at 460 nm and emission at 535 
nm). At approximately 200 s, addition of sodium dithionite (Na2S2O4) quenches NBD 
fluorescence leading to a drop in relative intensity to ~50%, indicating a predominantly 
unilamellar vesicle population. Vesicles are fully solubilized upon the addition of 400 
µM Triton X-100 at 400 s. The slow fluorescence decreases are due to photo bleaching 
effects.  
 
A2. Vesicle Assembly Protein Concentration Optimization 
 
This section describes the optimization of protein conditions in order to fully 
maximize the vesicle surface area occupied by hexagonal arrays. We used kinase activity 
and stoichiometry (optimal is 6 CF: 1 CheA: 2 CheW) measured in a sedimentation 
binding assay to determine optimal protein concentrations for vesicle assembly (see 
Chapter 2 for details). Previously, Weis and coworkers utilized vesicles at a total lipid 
concentration of 580 µM at a 1:1 ratio of DOPC:DOGS (Shrout et al., 2003; Montefusco 
et al., 2007). These experiments used 30 µM CF (≈1/10 of DOGS concentration) for 
complete binding of CF to DOGS, and used limiting concentrations of CheA (1.2 µM), 
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and CheW (5 µM) so that all of CheA and CheW would be bound to CF. Koshy 
subsequently identified conditions with excess CheA and CheW (30 µM CF, 6 µM 
CheA, and 12 µM CheW) with maximal activity on 580 µM vesicles (optimization 
detailed in (Koshy, 2013)) so that all of the CF would be incorporated into complexes 
with CheA and CheW.  
In addition to improving our preparation of unilamellar vesicles, we increased the 
total lipid concentration to 725 µM, maintaining 290 µM DOGS, in order to provide 
sufficient surface area for full hexagonal arrays of 30 µM CF. Thus, the optimization of 
new CheA and CheW concentrations was needed. To do so, we simultaneously changed 
CheA and CheW concentrations while keeping 30 µM CF (both CF4E and CF4Q) and 
725 µM vesicle constant. CheA and CheW conditions at different ratios ranging from 6–
24 µM were compared. For simplicity throughout this section, these conditions are 
labeled and referred to by the assembly concentration ratios of CheA to CheW (e.g. 6:12 
means 6 and 12 µM CheA and CheW, respectively), with 30 µM CF in each assembly, 
but omitted in the label. These values are different than the measured stoichiometries of 
the complex determined after assembly from the pellet ratios in the sedimentation assay 
(e.g. 6:1:2 is 6 CF to 1 CheA to 2 CheW).   
Optimal conditions for both CF4E and CF4Q assembly on 725 µM vesicles were 
chosen based on both the activity and complex stoichiometry. Many of the CheA and 
CheW concentrations tested promote similar activities, and likewise many assemblies had 
acceptable stoichiometries. These data were collected over the course of 2–3 days each 
for CF4E and CF4Q, and fresh vesicles were prepared and used no more than one day 
later. Replicate assembly ratios were prepared to carry over multiple days and account for 
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day-to-day variability. However, these replicates were reproducible, and no further 
correction of activities or ratios was necessary. For CF4E, 8:12 and 12:20 produced the 
highest activity with approximately 6:1:2 stoichiometries (Figure A.4.A and Table A.1). 
While 6:12 had the highest activity overall, this sample had only 2.9 µM CheA bound 
and the stoichiometry was 6:0.6:1.0, and thus below native levels. These conditions may 
be useful, however, if such stoichiometries were desired. CF4Q assemblies were typically 
more active than CF4E with greater CheA binding (Figure A.4.B and Table A.2). 12:24 
produced the highest activity and was therefore chosen as the optimal assembly condition 
for CF4Q. While this assembly had an elevated complex stoichiometry of 6:1.7:2.4, we 
note that most CF4Q assemblies were similarly higher than the native 6:1:2.  
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Figure A.4. Optimization of CheA and CheW concentrations for maximal kinase activity 
with vesicle assembly. CF4E (A) and CF4Q (B) were each assembled at 30 µM with 
varying concentrations of CheA and CheW that correspond to labels (e.g. 6:12 means 6 
and 12 µM CheA and CheW, respectively). Vesicle concentrations were kept constant at 
725 µM total lipid (with 290 µM DOGS). Total (black bars) and specific (gray bars) 
kinase activities are averages of two replicates and error bars indicate ± one standard 
deviation. Data are also listed in Table A.1 for CF4E, and A.2 for CF4Q, with 
corresponding [CheA]bound and pellet stoichiometries.  
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Table A.1. Kinase activities, CheA binding, and complex stoichiometries in CF4E 
vesicle assembly optimization 
 
CheA:CheW 
(µM)a 
Total 
Activity (s–1)b 
Specific 
Activity (s–1)c 
Bound 
CheA (µM) 
Stoichiometry 
(CF:CheA:CheW) 
6:6 2.35 ± 0.07 4.87 ± 0.15 2.9 6:0.4:0.5 
6:12 5.13 ± 0.04 11.40 ± 0.08 2.7 6:0.6:1.0 
8:12 3.38 ± 0.06 6.48 ± 0.12 4.0 6:0.8:1.2 
8:16 4.31 ± 0.01  8.61 ± 0.01 4.0 6:0.9:1.7 
10:20 3.29 ± 0.09 5.58 ± 0.15 5.9 6:1.5:1.5 
12:8 1.69 ± 0.01 5.19 ± 0.02 3.9 6:0.9:0.8 
12:12 2.62 ± 0.06 7.32 ± 0.17 4.3 6:1.1:1.3 
12:16 3.11 ± 0.14 6.33 ± 0.29 5.9 6:1.5:1.6 
12:20d 3.92 ± 0.10 9.41 ± 0.25 5.0 6:1.4:1.7 
12:24 3.29 ± 0.07 4.07 ± 0.09 9.7 6:1.7:2.4 
16:8 1.42 ± 0.01 5.15 ± 0.02 4.4 6:1.1:1.0 
16:12 1.93 ± 0.01 6.67 ± 0.03 4.6 6:1.2:1.3 
18:18 2.42 ± 0.11 8.52 ± 0.37 5.1 6:1.4:1.6 
 
a30 µM CF4E, 725 µM vesicles (435 µM DOPC and 290 µM DOGS-NTA-Ni2+) and 
varying concentrations of CheA and CheW (listed) in each assembly. 
bKinase activity per total CheA in assembly 
cKinase activity per bound CheA in assembly 
dOptimal conditions chosen for CF4E based on high activity, CheA binding, and 
stoichiometry. 
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Table A.2. Kinase activities, CheA binding, and complex stoichiometries in CF4Q 
vesicle assembly optimization 
 
CheA:CheW 
(µM)a 
Total 
Activity (s–1)b 
Specific 
Activity (s–1)c 
Bound 
CheA (µM) 
Stoichiometry 
(CF:CheA:CheW) 
6:6 4.32 ± 0.25 7.20 ± 0.42 3.6 6:0.8:0.8 
6:12 3.30 ± 0.37 5.82 ± 0.65 3.4 6:1.2:1.2 
12:12 4.60 ± 0.13 8.37 ± 0.23 6.6 6:1.8:1.9 
12:18 4.31 ± 0.07  8.08 ± 0.14 6.4 6:1.5:2.2 
12:20 5.38 ± 0.25 9.17 ± 0.43 7.0 6:1.7:1.8 
12:24d 6.54 ± 0.02 10.89 ± 0.03 7.2 6:1.7:2.4 
14:20 3.87 ± 0.04 6.77 ± 0.07 8.0 6:1.7:1.7 
16:24 4.39 ± 0.02 7.47 ± 0.03 9.4 6:2.0:1.6 
18:12 2.32 ± 0.10 5.23 ± 0.03 8.0 6:1.8:1.7 
18:18 2.53 ± 0.03 6.81 ± 0.07 6.7 6:1.6:2.0 
18:24 3.21 ± 0.05 8.76 ± 0.13 6.6 6:1.8:2.5 
24:12 1.92 ± 0.01 8.07 ± 0.04 5.7 6:1.3:1.1 
24:18 2.00 ± 0.01 10.02 ± 0.01 4.8 6:1.4:1.4 
 
a30 µM CF4Q, 725 µM vesicles (435 µM DOPC and 290 µM DOGS-NTA-Ni2+) and 
varying concentrations of CheA and CheW (listed) in each assembly. 
bKinase activity per total CheA in assembly 
cKinase activity per bound CheA in assembly 
dOptimal conditions chosen for CF4Q based on high activity, CheA binding, and 
stoichiometry. 
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